Introduction {#sec1}
============

Nonanolides are a class of molecules that belong to the family of secondary metabolites. The broad spectrum of biological activities (antimalarial, antituberculosis, anticancer, pesticide activity, and phytotoxic activity) and diverse architectural features of these medium-ring-sized molecules have created immense interest in the scientific community.^[@ref1],[@ref2]^ Several synthetic groups worldwide have contributed to the synthesis of nonanolides and related molecules.^[@ref2]^ Structurally nonanolides are 10-membered macrolides. Mostly, the core lactone framework is appended with a C-9 alkyl group, oxygenated functionalities, and a skeletal trans-olefin moiety. Zhang and co-workers, in 2011, discovered first five new cytotoxic nonanolides, cytospolides A--E (**1**--**5**) ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}), from the crude acetone extract of fungi, *Cytospora* sp. isolated from *Ilex canariensis*.^[@ref3]^ These are the first examples of nonanolides that possess an additional C-2 methyl group compared with the other existing nonanolides. The structures and absolute configurations of these natural products were elucidated using detailed NMR, mass spectrometry, and X-ray crystallographic analysis and by combining time-dependent density functional theory calculations of circular dichroism data. Architecturally, cytospolides A--C (**1**--**3**) are the acetyl derivatives of cytospolide D (**4**), whereas cytospolide E (**5**) is the C-2 epimer of cytospolide D. The stereochemical difference of the C-2 methyl group in cytospolides D and E is manifested in their cytotoxic activities. Cytospolide E (**5**) having a C-2 methyl group of (S)-configuration is more toxic (IC~50~ ∼ 10 μM) to human lungs carcinoma cell line A549 compared with cytospolide D (**4**), in which the C-2 methyl center is in the opposite configuration.^[@ref3]^ In continuation of our program^[@ref4]^ toward the asymmetric synthesis of bioactive macrocyclic natural products and their analogues, we embarked on the total synthesis of cytospolide E (**5**). A number of synthetic reports on cytospolides D and E exist in the literature. Yadav,^[@ref5]^ Nanda,^[@ref6]^ and Ramana^[@ref7]^ et al. have shown, separately, the synthesis of Z-isomer of cytospolide E using the late-stage ring-closing metathesis (RCM)-based macrocyclization strategy. The Z-isomer of cytospolide D was also synthesized by Kamal^[@ref8]^ and Nanda^[@ref6]^ et al. using the RCM approach. However, the total synthesis of naturally occurring cytospolide D was successfully achieved independently by Kamal^[@ref8]^ and Nanda^[@ref9]^ et al. using the classical macrolactonization approach. Later, Stark et al.^[@ref10]^ developed an elegant synthetic route for the total synthesis of cytospolide D adopting the macrolactonization strategy. The utility of macrolactonization for the synthesis of cytospolide E was also tested by Ramana et al.,^[@ref7]^ but a dimeric 20-membered macrocycle was obtained rather than the actual natural product. The total synthesis of cytospolide E has not been successful till date. Thus, exploration of different possible synthetic routes toward the total synthesis of cytospolide E is essential. In this article, we report our efforts toward the synthesis of cytospolide E, in detail, which eventually produced 8-*epi*-9-*epi*-cytospolide E along with a previously reported macrocyclic skeleton with Z-olefin.

![Chemical structures of cytospolides A--E (**1**--**5**).](ao-2017-01893q_0012){#fig1}

Results and Discussion {#sec2}
======================

Ring-Closing Metathesis Approach {#sec2.1}
--------------------------------

Scrutiny of literature revealed that apart from reaction conditions and the nature of catalysts the skeletal substituent/functionality of the reactant plays a pivotal role in the stereochemical outcome of the RCM reaction.^[@ref11]^ This prompted us to rely first on the RCM^[@cit4e],[@ref12]^-based macrocyclization strategy even though a number of reports^[@ref5]−[@ref8]^ toward the synthesis of cytospolides D and E demonstrated its problem toward E-selective metathesis. Careful analysis of these reports revealed that in most of the cases both the allylic and bishomoallylic hydroxy groups of the RCM precursor were protected either as smaller methoxymethyl (MOM) ethers, as benzyl ethers, or as a mixture of a similar class of protecting groups like benzyl and *p*-methoxy benzyl ether. We anticipated that the changes in the skeletal framework might help in achieving a favorable conformation toward the E-selective RCM. This possibility could be explored either by varying the protecting group on the hydroxy centers or by removing some of the skeletal functionality, which could be installed in the later stage of synthesis or by modifying the structure of olefins. Moreover, during the total synthesis of cytospolide P, we have observed that the presence of bulky allylic *tert*-butyldimethylsilyl (TBS) ether facilitated the formation of the E-selective RCM product.^[@cit4e]^ Consolidating these facts and our own experiences, we planned the retrosynthesis of cytospolide E (**5**) as depicted in [Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}, where the role of protecting groups ought to be investigated with the goal of optimizing the best possible conditions allowing the total synthesis. Therefore, cytospolide E was planned to be synthesized from compound **7** via cyclic intermediate **6** using RCM as one of the key steps. It was decided that the allylic hydroxy functionality of compound **7** would be protected by a bulky TBS ether as it is adjacent to the reaction site. Compound **7** could further be constructed from alcohol **8** and acid **9** using intermolecular esterification as one of the pivotal steps.

![Initial Retrosynthetic Analysis of Cytospolide E (**5**)](ao-2017-01893q_0001){#sch1}

Our initial efforts toward the synthesis of cytospolide E are delineated in [Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}. We started our synthesis from known epoxy alcohol **10**,^[@ref13]^ which was protected as benzyl ether using BnBr/NaH to result in compound **11**. The epoxy functionality of compound **11** was then opened using allyl magnesium bromide in the presence of CuCN to get the corresponding alkenol, which was further reacted with methoxymethyl chloride (MOMCl)/*N*,*N*-diisopropylethylamine (DIPEA) followed by Li/naphthalene to access another alkenol **8** in good overall yield (61% in three steps). The known acid **9**([@ref14]) was then esterified with alkenol **8** using the Steglich protocol^[@ref15]^ to get ester **7** in 79% yield. The stage was set to carry out the crucial RCM reaction. G-II and HG-II catalysts were screened under different reaction conditions. It was observed that in both the cases a linear homodimer (**13**) was formed as a major product along with an inseparable trace amount of 10-membered macrolide (**12**). The identity of macrolide (**12**) was confirmed only by mass spectroscopy, which restricted us to characterize the geometry of olefin embedded in the cyclic structure. The formation of linear homodimer **13** as a major product could be reasoned to be due to the presence of bulky TBS ether. This might have exerted a steric constraint around the allylic olefin to make it reluctant toward olefin metathesis. Next, we were keen to see whether the removal of allylic TBS ether would have any effect on the outcome of the RCM reaction. Therefore, compound **14** was prepared from compound **7** using tetrabutylammonium fluoride (TBAF). It was then subjected to the RCM reaction separately using G-II and HG-II catalysts.^[@ref12]^ Unfortunately, in both the cases, compound **15** was formed with Z-selectivity in 46% yield along with 14% of cyclic dimer **16**. This compelled us to look for an alternative strategy.

![Initial Efforts toward the Total Synthesis of Cytospolide E\
Reagents and conditions: (a) BnBr, NaH, tetrabutylammonium iodide (TBAI), 0 °C to room temperature (rt), 4 h, 86%; (b) (i) allyl magnesium chloride, CuCN, tetrahydrofuran (THF), 0 °C to rt, 2 h, 83%; (ii) MOMCl, DIPEA, CH~2~Cl~2~, 0 °C to rt, 3 h, 88%; (iii) Li, naphthalene, THF, −40 °C, 30 min, 82%; (c) **9**, *N*,*N*′-diisopropyl carbodiimide (DIC), 4-dimethylaminopyridine (DMAP), CH~2~Cl~2~, rt, 4 h, 79%; (d) G-II or HG-II, CH~2~Cl~2~, reflux, 13 h, 37% with respect to (wrt) compound **13**; (e) TBAF, THF, 0 °C to rt, 3 h, 91%; (f) G-II, CH~2~Cl~2~, reflux, 2.5 h, 46% wrt compound **15**, 14% wrt compound **16**.](ao-2017-01893q_0010){#sch2}

Then, we planned for possible structural changes in the RCM precursor by converting one of the hydroxy groups into keto functionality, from which the required center could be reinstalled at an advanced stage of synthesis. During this exercise, we targeted bishomoallylic alcohol rather than allylic alcohol because the conversion of allylic alcohol to keto functionality might have sensitized the C-2 methyl group toward racemization as it would be flanked between two carbonyl functionalities. Thus, we planned for compound **17**, which could be synthesized from the known acid **19** and alcohol **20** through RCM precursor **18** ([Scheme [3](#sch3){ref-type="scheme"}](#sch3){ref-type="scheme"}). Our synthetic endeavor started from the known compound **22**([@ref5]) prepared from compound **10**([@ref13]) via intermediate **21** following the literature protocol, which was then oxidized to the corresponding keto by Dess−Martin periodinane (DMP) and subsequently treated with TBAF to get compound **20**. This was then esterified with the known acid **19**([@ref5],[@ref6]) using the Yamaguchi protocol^[@cit4e],[@ref16]^ to get ester **18**, which was subjected to RCM separately using G-II and HG-II. Unfortunately, in both the cases, macrolide **23** with Z-olefin was formed along with cyclic dimer **24** ([Scheme [3](#sch3){ref-type="scheme"}](#sch3){ref-type="scheme"}). This forced us to look for other possibility.

![Efforts toward the Synthesis of Compound **17**\
Reagents and conditions: (a) *tert*-butyldimethylsilyl chloride, imidazole, CH~2~Cl~2~, 0 °C to rt, 2.5 h, 98%; (b) allyl magnesium chloride, CuCN, THF, 0 °C to rt, 3 h, 85%; (c) (i) DMP, NaHCO~3~, CH~2~Cl~2~, 0 °C to rt, 3 h, 95%, (ii) TBAF, THF, 0 °C to rt, 5 h, 92%; (d) **19**, 2,4,6-trichlorobenzoyl chloride, Et~3~N, DMAP, CH~2~Cl~2~, rt, 3.5 h, 78%; (e) G-II, CH~2~Cl~2~, reflux, 3.5 h, 51% wrt compound **23**, 13% wrt compounds **24**.](ao-2017-01893q_0009){#sch3}

A number of reports^[@cit2d]−[@cit2i]^ exist in the literature for the synthesis of a wide range of nonanolides having a skeletal trans-olefin moiety using the RCM strategy. Noticeably, in most of those cases, the C-2 position is either unsubstituted or substituted with the oxygenated center. This prompted us to envisage whether a macrocycle without a C-2 methyl group could be prepared from which the construction of a complete cytospolide E framework would be achieved by C-methylation in the advanced stage of synthesis. Thus, compound **25** was planned as the next target that could be synthesized from acid **27** and alcohol **8** via intermediate **26** ([Scheme [4](#sch4){ref-type="scheme"}](#sch4){ref-type="scheme"}). During the choice of protection groups of compound **27**, we conceived the same logic as that followed for compound **7** even though the allylic TBS ether made it reluctant toward RCM. This approach might help evaluating the role of allylic TBS in making compound **7** inefficient toward RCM. We started our synthesis from known compound **28**([@ref17]) prepared from [d]{.smallcaps}-aspartic acid following a literature protocol.^[@ref18]^ Compound **28** was subjected to (2,2,6,6-tetramethylpiperidin-1-yl)oxyl (TEMPO)/bis(acetoxy)iodobenzene (BAIB)-mediated oxidation^[@cit4f]^ to get acid **27** in 84% yield. Acid **27** was then esterified with alcohol **8** to obtain ester **26** following the Steglich conditions.^[@ref15]^ Both the G-II and HG-II catalysts were screened separately for RCM. Unfortunately, in both the cases, compound **29** was formed in 39% yield along with some unidentified side products. This result demonstrated that apart from the allylic TBS group the remote C-2 methyl group also played a major role to make compound **7** ([Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}) inefficient toward RCM although the reason is not clearly understood.

![Efforts toward the Synthesis of Compound **25**\
Reagents and conditions: (a) TEMPO, BAIB, CH~2~Cl~2~/H~2~O (1:1), rt, 3 h, 84%; (b) **8**, DIC, DMAP, CH~2~Cl~2~, rt, 4 h, 81%; (c) G-II, CH~2~Cl~2~, reflux, 8 h, 39%.](ao-2017-01893q_0002){#sch4}

It was observed that changes of protection groups or functionalities did not result in any E-selective RCM in our cases. It is evident in the literature that structures of olefins also play an important role in the RCM reaction as they participated directly in the formation of the metallocycle intermediate.^[@cit19a]^ Thus, we planned to modify the structure of one of the olefins. For this exercise, we chose initially the C~4~--C~5~ olefin. We planned to protect the hydroxy groups with small protecting groups as it was observed that bulky allylic groups made the RCM reaction more sluggish without offering the desire selectivity. Therefore, we planned to synthesize compound **30** from compounds **32** and **8** through the key intermediate **31** utilizing the RCM approach ([Scheme [5](#sch5){ref-type="scheme"}](#sch5){ref-type="scheme"}). We started our synthesis from the known intermediate **33**([@ref20]) prepared from cinammaldehyde following a literature protocol, which was treated with MOMCl/DIPEA followed by LiOH·H~2~O/30% H~2~O~2~ to get acid **32**. The previously synthesized alcohol **8** was then esterified with acid **32** following the Steglich protocol^[@ref15]^ to get compound **31** in good yield (83%). Both G-II and HG-II catalysts were tested. Unfortunately, the phenyl-substituted olefin became inert toward metathesis in both the cases. The less hindered olefin participated in cross metathesis to culminate a liner homo dimer **34** almost exclusively, which discouraged us to attempt RCM further with phenyl-substituted C~5′~--C~6′~ olefin. We were thus prompted to consider a different substituted olefin.

![Efforts toward the Synthesis of Compound **30** Using a Phenyl-Substituted Olefin\
Reagents and conditions: (a) (i) MOMCl, DIPEA, CH~2~Cl~2~, 0 °C to rt, 3 h, 89%; (ii) LiOH·H~2~O, 30% H~2~O~2~, THF/H~2~O (3:1), 0 °C to rt, 8 h, 81%; (b) **8**, DIC, DMAP, CH~2~Cl~2~, rt, 4 h, 83%; (c) G-II, CH~2~Cl~2~, reflux, 12 h, 38%.](ao-2017-01893q_0011){#sch5}

The use of pinacol boron-substituted olefin in E-selective cross-olefin metathesis is well-documented.^[@ref19]^ We were keen to see whether this approach could be utilized in RCM to achieve compound **30** ([Scheme [6](#sch6){ref-type="scheme"}](#sch6){ref-type="scheme"}). Thus, ester **35** was conceived as the next RCM precursor, which could be constructed further from acid **19** and alcohol **36**. The less hindered C~5′~--C~6′~ olefin was selected to be substituted with pinacol boron as the other olefin with the allylic substituent itself was sluggish toward RCM in our cases. The previously prepared olefin **8** was subjected to cross metathesis^[@ref21]^ with vinyl-B(pin) (**37**) using G-II to get alcohol **36** in very good yield and selectivity. Next, alcohol **36** was esterified with known acid **19** using Steglich conditions.^[@ref15]^ Both G-II and HG-II were screened for RCM under different conditions. The G-II catalyst participated faster in metathesis compared with the HG-II catalyst like all of the earlier cases. However, it was quite unfortunate that compound **38** was formed as an exclusive product. No macrocycle with E-olefin was detected that prompted us to move for another macrocyclization approach.

![Efforts toward the Synthesis of Compound **30** Using a B(pin)-Substituted Olefin\
Reagents and conditions: (a) **37**, G-II, CH~2~Cl~2~, reflux, 6 h, 64%; (b) **19**, DIC, DMAP, CH~2~Cl~2~, rt, 7 h, 49%; (c) G-II, CH~2~Cl~2~, reflux, 4 h, 68%.](ao-2017-01893q_0003){#sch6}

Macrolactonization Approach {#sec2.2}
---------------------------

At this point, we decided to explore the classical macrolactonization strategy for the target molecule. Ramana et al.^[@ref7]^ also have adopted this approach during their synthetic study of cytospolide E, where the C-3 and C-8 hydroxy groups of the seco acid were in a protected form. This eventually resulted in a dimeric macrocyclic lactone rather than the required 10-membered macrocycle. We wondered whether multiple protected alcohol functionalities on the seco acid would have created an unfavorable situation toward the formation of a 10-membered macrocycle. Thus, we felt the need to explore this approach using a seco acid with fewer hydroxy-protected functionalities. This could be possible if the regioselective formation of one macrocycle could be tuned over other possible macrocycle by taking the advantage of the skeletal olefin moiety. Niwa et al.^[@ref21]^ have also adopted a similar concept during the total synthesis of unnatural (+)-neodidemnilactone having skeletal Z-olefin. They successfully constructed the 10-membered macrocycle over a possible 9-membered macrocycle in moderate yield. Therefore, we sketched the retrosynthesis of cytospoilde E (**5**) as depicted in [Scheme [7](#sch7){ref-type="scheme"}](#sch7){ref-type="scheme"}, which could be synthesized from seco acid **39** where only the C-3 hydroxy would be suitably protected. Seco acid **39** could be constructed from compound **41** via intermediate **40** using modified Crimmins aldol as one of the key steps.

![Initial Retrosynthetic Analysis of Cytospolide E (**5**) Using the Macrolactonization Strategy](ao-2017-01893q_0004){#sch7}

To test the hypotheses of regioselective formation of the 10-membered ring over the 9-membered macrocycle in the presence of a trans-olefin moiety embedded in the reacting seco acid, we followed [Scheme [8](#sch8){ref-type="scheme"}](#sch8){ref-type="scheme"}. We started our synthesis from *cis*-4-decen-1-ol (**42**), which was converted to a mixture of enantiomers **43** and **43a** by sequential treatment with OsO~4~/*N*-methylmorpholine-*N*-oxide (NMO) followed by 2,2-dimethoxypropane (2,2-DMP)/camphorsulfonic acid (CSA). Next, the mixture of compounds (**43** and **43a**) was subjected to Swern oxidation followed by Wittig olefination in the presence of ethyl(triphenylphosphoranylidene)acetate to yield the corresponding α,β-unsaturated ester. The ester moiety was reduced with diisobutylaluminium hydride (DIBAL-H) to get the racemic mixture of allylic alcohols **41** and **41a**. This was then oxidized to the corresponding aldehydes using Swern conditions and subsequently was subjected to TiCl~4~-mediated modified Crimmins aldol reaction^[@cit4a],[@ref22]^ in the presence of oxazolidinone **44**([@ref22]) to get an inseparable mixture of diastereomers. Interestingly, the ^1^H and ^13^C NMR spectra of these two diastereomers were so identical that it was difficult to sense the presence of a mixture of compounds at the first glance. The aldol adducts were protected as TBS ether with *tert*-butyldimethylsilyl trifluoromethanesulfonate (TBSOTf)/2,6-lutidine to get the mixture of compounds **40** and **40a**, which was then saponified using LiOH·H~2~O to obtain the corresponding acid as an inseparable mixture. Next, we have tried different reagents (CSA, AcOH) in different conditions for selective deprotection of acetonide in the presence of TBS ether, but none of them functioned well. It was our great relief that Zn(NO~3~)~2~·6H~2~O was found to be effective.^[@ref23]^ An inseparable mixture of seco acids **39** and **39a** was obtained, which was then subjected to crucial macrolactonization following the Yamaguchi protocol.^[@cit4d],[@cit16d]^ A complex mixture was formed, which was subsequently desilylated with TBAF to get lactone **45** as the only isolable product with 22% yield. The formation of lactone **45** was confirmed by high-resolution mass spectrometry (HRMS). However, the ^1^H and ^13^C NMR data of this lactone did not match with the reported data of isolated cytospolide E. Thus, we looked first for the possibility of the formation of a nine-membered lactone. Detailed two-dimensional (2D)-NMR studies were carried out. It could be argued that if the C-8 hydroxy group took part in lactone ring formation then the corresponding C-8 proton must have a correlation with C-7 proton(s). However, the ^1^H--^1^H correlated spectroscopy experiment showed no such correlation but rather a correlation with C-10 protons. This observation ruled out the possibility of a nine-membered ring formation. The chance of epimerization of the C-2 center was also not taken into account because its NMR data was not in accordance with that for cytospolide D,^[@ref3]^ which is a C-2 epimeric product of cytospolide E. This confirmed that lactone **45** is the 8-*epi*-9-*epi* isomer of cytospolide E. It might be the case that the required seco acid did not cyclize, which would have decomposed during the reaction. This result prompted us to synthesize the required seco acid having stereochemically pure C-8 and C-9 hydroxy centers to understand its fate during macrolactonization.

![Test of Viability of Regioselective Formation of the 10-Membered Ring over the 9-Membered Macrocycle\
Reagents and conditions: (a) (i) OsO~4~, NMO, *^t^*BuOH/THF (1:1), 0 °C to rt, 7 h, (ii) 2,2-DMP, CSA, CH~2~Cl~2~, 0 °C to rt, 3 h, 84% over two steps; (b) (i) (COCl)~2~, dimethyl sulfoxide (DMSO), Et~3~N, CH~2~Cl~2~, −78 to 0 °C, 1.5 h, (ii) PPh~3~=CHCO~2~Et, toluene, 80 °C, 6 h, (iii) DIBAL-H, CH~2~Cl~2~, −78 °C, 30 min, 71% over three steps; (c) (i) (COCl)~2~, DMSO, Et~3~N, CH~2~Cl~2~, −78 to 0 °C, 2 h, (ii) **44**, TiCl~4~, DIPEA, *N*-methylpyrrolidone (NMP), CH~2~Cl~2~, 0 °C, 2 h, (iii) 2,6-lutidine, TBSOTf, CH~2~Cl~2~, 0 °C to rt, 30 min, 72% over three steps; (d) (i) LiOH·H~2~O, 30% H~2~O~2~, THF/H~2~O (3:1), 0 °C to rt, 10 h, (ii) Zn(NO~3~)~2~·6H~2~O, CH~3~CN, 6 h, 49% over two steps; (e) (i) 2,4,6-trichlorobenzoyl chloride, Et~3~N, THF, rt, 6 h, then DMAP, toluene, 80 °C, 10 h, then 12 h at rt, (ii) TBAF, THF, 0 °C to rt, 3 h, 22% over two steps based on one isomer.](ao-2017-01893q_0005){#sch8}

Attempt toward the synthesis of cytospolide E with a stereogenically pure substrate is shown in [Scheme [9](#sch9){ref-type="scheme"}](#sch9){ref-type="scheme"}. Compound **46** was prepared from [l]{.smallcaps}-arabinose following the literature procedure.^[@ref13]^ This was then oxidized using Swern conditions followed by the Wittig olefination to get the corresponding α,β-unsaturated ester, which was treated further with LiCl/NaBH~4~. An inseparable mixture of alcohols with and without the olefin was obtained, which was finally hydrogenated to ensure the completely saturated product **43** in 70% overall yield. Alcohol **43** was then converted to seco acid **39** through intermediates **41** and **47** following the similar chemistry as mentioned above. Next, seco acid **39** was subjected to macrolactonization. A number of macrolactonization protocols like Shiina,^[@cit4d],[@cit16d],[@ref24]^ Yamaguchi,^[@cit4d],[@cit16d]^ and Steglich^[@ref15]^ have been attempted under different reaction conditions. Unfortunately, none of them were effective. In every case, either the seco acid decomposed or it produced a complex mixture, which was quite difficult to isolate or characterize.

![Attempts toward the Synthesis of Cytospolide E Using the C-3 Hydroxy Group in a Protected Form\
Reagents and conditions: (a) (i) (COCl)~2~, DMSO, Et~3~N, CH~2~Cl~2~, −78 to 0 °C, 2 h and then PH~3~P=CHCO~2~C~2~H~5~, rt, 10 h, (ii) LiCl, NaBH~4~, THF/EtOH (2:1), 0 °C to rt, 7 h, (iii) 10% Pd/C, H~2~, 10 h, 70% yield over three steps; (b) (i) (COCl)~2~, DMSO, Et~3~N, CH~2~Cl~2~, −78 to 0 °C, 2 h, (ii) PPh~3~=CHCO~2~Et, toluene, 80 °C, reflux, 6 h, 79%, (iii) DIBAL-H, CH~2~Cl~2~, −78 °C, 30 min, 69% over three steps; (c) (i) (COCl)~2~, DMSO, Et~3~N, CH~2~Cl~2~, −78 to 0 °C, 2 h, (ii) **44**, TiCl~4~, DIPEA, NMP, CH~2~Cl~2~, 0 °C, 2 h, 80% over two steps; (d) (i) 2,6-lutidine, TBSOTf, CH~2~Cl~2~, 0 °C to rt, 30 min, (ii) LiOH·H~2~O, 30% H~2~O~2~, THF/H~2~O (3:1), 0 °C to rt, 10 h, (iii) Zn(NO~3~)~2~·6H~2~O, CH~3~CN, 6 h, 53% over three steps; (e) (i) LiCl, NaBH~4~, THF/EtOH (2:1), 0 °C to rt, 8 h, (ii) *p*-methoxybenzyl (PMB)-acetal, CSA, CH~2~Cl~2~, 0 °C to rt, 1 h, (iii) DIBAL-H, CH~2~Cl~2~, 0 °C, 30 min, (iv) TEMPO, BAIB, CH~2~Cl~2~/H~2~O (1:1), 3 h, (v) Zn(NO~3~)~2~·6H~2~O, CH~3~CN, 80 °C, 2 h, 34% over five steps; (f) 2-methyl-6-nitrobenzoic anhydride, DMAP, 4 Å MS, CH~2~Cl~2~, rt, 12 h.](ao-2017-01893q_0007){#sch9}

We reasoned that the steric crowding due to the presence of a bulky TBS ether at the C-3 position might be a cause of unsuccessful macrolactonization. Accordingly, we planned for seco acid **48** having a relatively less sterically constrained PMB ether at the C-3 position. Initially, the protection of the free hydroxy of compound **47** as a PMB ether was attempted using PMB-chloromidate in the presence of TfOH or CSA, but the starting material decomposed completely. Next, compound **47** was reacted with LiCl/NaBH~4~ to obtain the corresponding diol, which was further reacted with *p*-methoxy benzyl dimethoxy acetal in the presence of a catalytic amount of CSA to furnish the corresponding acetal. This was then opened regioselectively with DIBAL-H to get the corresponding primary alcohol, which directly converted to the corresponding acid using TEMPO/BAIB.^[@cit4f]^ Finally, the acid was subjected to selective acetonide deprotection in the presence of Zn(NO~3~)~2~·6H~2~O^[@ref23]^ to provide the requisite seco acid **48** in 34% overall yield (in five steps). The stage was set for crucial macrolactonization. It was observed that a complex mixture was formed under Steglich conditions, whereas the staring material decomposed completely under Yamaguchi conditions. Interestingly, the Shiina macrolactonization protocol provided a mixture of macrocyclic dimers, confirmed by HRMS. This result suggested that the cyclization of a C-3 unprotected seco acid might help us to achieve the desired result. In this context, it did not appear realistic to proceed with three unprotected hydroxy groups. Therefore, we planned to protect the C-8 hydroxy group as a MOM ether and manipulated the precursors accordingly.

Efforts toward the synthesis of cytospolide E using the C-8 hydroxy group in a protected form is described in [Scheme [10](#sch10){ref-type="scheme"}](#sch10){ref-type="scheme"}. Previously synthesized compound **22** was treated with MOMCl/DIPEA to get the corresponding MOM ether and subsequently was subjected to oxidative cleavage using OsO~4~/NaIO~4~ to obtain the corresponding aldehyde. The resultant aldehyde was then reacted with ethyl(triphenylphosphoranylidene)acetate following the Wittig olefination protocol followed by treatment with DIBAL-H to yield allylic alcohol **49** in 58% overall yield. Alcohol **49** was then oxidized to the corresponding aldehyde using Swern conditions and subsequently was subjected to the modified Crimmins aldol reaction^[@ref22]^ in the presence of auxiliary **44**([@ref22]) to obtain compound **50** in 77% yield. Next, compound **50** was saponified in the presence of LiOH·H~2~O/30%H~2~O~2~ to get the corresponding acid. Our initial efforts to deprotect the TBS ether to get the required seco acid **51** were not successful. This compelled us to change our strategy. We planned first to deprotect the TBS ether and then install the acid functionality. Therefore, compound **50** was treated initially with TBAF, which eventually produced an eliminated product rather than the required desilylated product. We speculated that a milder desilylating agent might solve this problem. Thus, HF-py in THF was tested. We were delighted to see that the corresponding desilylated product was obtained in very good yield (88%), which was subsequently saponified in the presence of LiOH·H~2~O/30% H~2~O~2~ to obtain seco acid **51** in 84% yield. Seco acid **51** was then subjected to macrolactonization. Both Shiina and Yamaguchi protocols were tested. Unfortunately, no satisfactory results were obtained. In both the cases, the starting material either remained unreacted as a mixed anhydride or decomposed completely.

![Attempt toward the Synthesis of Cytospolide E Using the C-8 Hydroxy Group in a Protected Form\
Reagents and conditions: (a) (i) MOMCl, DIPEA, CH~2~Cl~2~, 0 °C to rt, 3 h, (ii) OsO~4~, NaIO~4~, NaHCO~3~, CH~3~CN/H~2~O (1:1), 0 °C to rt, 6 h, (iii) PPh~3~=CHCO~2~Et, toluene, 80 °C, reflux, 6 h, (iv) DIBAL-H, CH~2~Cl~2~, −78 °C, 30 min, 58% over four steps; (b) (i) (COCl)~2~, DMSO, Et~3~N, CH~2~Cl~2~, −78 to 0 °C, 2 h, (ii) **44**, TiCl~4~, DIPEA, NMP, CH~2~Cl~2~, 0 °C, 2 h, 77% over two steps; (c) (i) HF-py, THF, 0 °C to rt, 3 h, 88%, (ii) LiOH·H~2~O, 30% H~2~O~2~, THF/H~2~O (3:1), 6 h, 84%.](ao-2017-01893q_0008){#sch10}

Conclusions {#sec3}
===========

In summary, we have documented various synthetic approaches toward the total synthesis of cytospolide E. The ring-closing metathesis approach provided a 10-membered macrocycle embedded with skeletal Z-olefin as a major product. It was further observed that changes in reaction conditions and the structure of the RCM precursor did not result in the required E-olefinic product, clearly indicating that the above-mentioned factors do not affect the transition state enough to favor an E-selective RCM. Thus, we believe that the RCM-based macrocyclization strategy is unsuitable for the synthesis of cytospolide E. On the other hand, the macrolactonization approach did not produce the required macrocycle either. However, 8-*epi*-9-*epi*-cytospolide E was synthesized by the regioselective macrolactonization of the 10-membered macrocycle over the possible 9-membered macrocycle from an isomeric mixture of seco acids. This result demonstrates that the stereochemistry of the C-2 methyl group plays a crucial role in macrolactonization. This is further supported by the fact that cytospolide D, with an inverted configuration of the C-2 methyl center relative to that of cytospolide E, was synthesized by others, albeit the yield was very low. It is noteworthy that a seco acid having only a C-3 hydroxy protecting group provided a 10-membered lactone with E-olefin, although C-8 stereochemistry and C-9 stereochemistry are in opposite configuration relative to the required one. We are of the opinion that macrolactonization is a viable approach to achieve the unique architecture of cytospolide E. However, further explorations based on functional group conversions, especially around the C-8 and C-9 centers, are essential before a successful synthesis is achieved. Efforts are presently in progress in that direction in our laboratory to accomplish the total synthesis of cytospolide E, which will be reported in due course.

Experimental Section {#sec4}
====================

General Experimental Procedure {#sec4.1}
------------------------------

All moisture-sensitive reactions were performed in oven or flame-dried glassware with a Teflon-coated magnetic stirring bar under an argon atmosphere using dry, freshly distilled solvents, unless otherwise noted. Air- and moisture-sensitive liquids were transferred via a gastight syringe and a stainless steel needle. Reactions were monitored by thin layer chromatography (TLC, silica gel 60 F254) plates where ethanolic anisaldehyde (with 1% AcOH and 3.3% conc. H~2~SO~4~)-heat and aqueous KMnO~4~ (with K~2~CO~3~ and 10% aqueous NaOH solution) were used as developing agents. All workup and purification procedures were carried out with reagent-grade solvents under an ambient atmosphere unless otherwise stated. Column chromatography was performed using silica gel 60--120 mesh, 100--200 mesh, and 230--400 mesh. Yields were mentioned as chromatographically and spectroscopically homogeneous materials unless otherwise stated. Optical rotations were measured only for pure compounds and not for mixtures using a sodium (589, D line) lamp and are reported as follows: \[α\]~D~^25^ (*c* = mg/100 mL, solvent). IR spectra were recorded as thin films (for liquids). HRMS was performed using a quadruple-TOF micro-MS system using the electrospray ionization (ESI) technique. ^1^H NMR spectra were recorded on 300, 400, and 500 MHz spectrometers in appropriate solvents and calibrated using a residual undeuterated solvent as an internal reference, and the chemical shifts are shown in parts per million (ppm) scales. Multiplicities of NMR signals are designated as s (singlet), d (doublet), t (triplet), q (quartet), br (broad), m (multiplet, for unresolved lines), etc. ^13^C and 2D-NMR spectra were recorded on 75, 100, and 125 MHz spectrometers.

### (*S*)-2-((*R*)-1-(Benzyloxy)hexyl)oxirane (**11**) {#sec4.1.1}

To a stirred suspension of NaH (60%, 1.67 g, 41.60 mmol) in anhydrous THF (100 mL) at 0 °C under argon, a solution of known epoxy alcohol **10** (5.0 g, 34.67 mmol) dissolved in anhydrous THF (50 mL) was added dropwise. The reaction mixture was stirred for 1 h at the same temperature. Benzyl bromide (4.95 mL, 41.60 mmol) was then added over a period of 10 min. Finally, TBAI (0.64 g, 1.73 mmol) was added, and the reaction mixture was warmed slowly to room temperature and stirred further for 3 h. The reaction was then quenched by slow addition of cold water (10 mL). The aqueous layer was extracted with EtOAc (3 × 100 mL), washed with water and brine, dried over Na~2~SO~4~, filtered, and concentrated in vacuo. Purification of the crude residue by flash column chromatography (SiO~2~, 230--400 mesh, 2--9% EtOAc in hexane as eluent) afforded benzyl ether **11** (6.98 g, 86%) as a colorless liquid: *R*~f~ = 0.50 (5% EtOAc/hexane); ^1^H NMR (CDCl~3~, 300 MHz) δ 7.36--7.24 (m, 5H), 4.65 (d, *J* = 11.4 Hz, 1H), 4.50 (d, *J* = 11.4 Hz, 1H), 3.28--3.22 (m, 1H), 2.94--2.90 (m, 1H), 2.77 (dd, *J* = 5.4, 3.9 Hz, 1H), 2.71 (dd, *J* = 5.4, 2.7 Hz, 1H), 1.67--1.59 (m, 2H), 1.59--1.47 (m, 1H), 1.44--1.25 (m, 5H), 0.88 (t, *J* = 6.9 Hz, 3H); ^13^C NMR (CDCl~3~, 75 MHz) δ 138.7, 128.4, 127.8, 127.7, 78.2, 72.4, 53.7, 45.7, 32.9, 31.9, 24.9, 22.7, 14.1 ppm; IR (neat) ν~max~ 2929, 2859, 1454, 1091, 733, 696 cm^--1^; HRMS (ESI) *m*/*z* calcd for C~15~H~22~O~2~Na \[M + Na\]^+^ 257.1518, found 257.1517.

### (5*S*,6*R*)-5-(Methoxymethoxy)undec-1-en-6-ol (**8**) {#sec4.1.2}

To an ice-cold stirred solution of epoxide **11** (2.5 g, 10.67 mmol) in anhydrous THF (30 mL) under argon, CuCN (143 mg, 1.60 mmol) and allyl magnesium chloride (8.0 mL, 2 M in THF, 16.0 mmol) were added sequentially. The reaction mixture was stirred further for 1 h at the same temperature and then for 2 h at room temperature. The reaction was then quenched with a saturated aqueous solution of NH~4~Cl (5 mL) at 0 °C. The mixture was extracted with EtOAc (2 × 50 mL), washed with water and brine, dried over Na~2~SO~4~, filtered, and concentrated in vacuo. Purification of the crude residue by flash column chromatography (SiO~2~, 100--200 mesh, 5--12% EtOAc in hexane as eluent) afforded the corresponding compound (2.44 g, 83%) as a clear liquid: *R*~f~ = 0.40 (10% EtOAc/hexane); \[α\]~D~^25^ = +9.7 (*c* 1.6, CHCl~3~); ^1^H NMR (CDCl~3~, 300 MHz) δ 7.35--7.25 (m, 5H), 5.91--5.77 (m, 1H), 5.08--4.96 (m, 2H), 4.57 (dd, *J* = 14.7, 11.7 Hz, 2H), 3.84--3.77 (m, 1H), 3.38--3.33 (m, 1H), 2.35--2.23 (m, 1H), 2.17--2.03 (m, 2H), 1.63--1.41 (m, 5H), 1.33--1.28 (m, 5H), 0.88 (t, *J* = 6.9 Hz, 3H); ^13^C NMR (CDCl~3~, 75 MHz) δ 138.6, 128.5, 127.9, 127.8, 115.0, 82.4, 72.1, 71.3, 32.1, 31.2, 30.5, 28.9, 25.6, 22.7, 14.2 ppm; IR (neat) ν~max~ 3451, 2929, 2858, 1454, 1070 cm^--1^; HRMS (ESI) *m*/*z* calcd for C~18~H~28~O~2~Na \[M + Na\]^+^ 299.1987, found 299.1985.

To a stirred solution of the above compound (1.48 g, 5.35 mmol) in anhydrous CH~2~Cl~2~ (15 mL) under argon at 0 °C, DIPEA (1.86 mL, 10.7 mmol) and MOMCl (0.61 mL, 8.0 mmol) were added sequentially. The reaction mixture was allowed to attain room temperature and stirred further for 3 h before quenching with water (5 mL). The organic layer was separated, and the aqueous part was extracted with EtOAc (2 × 30 mL). The combined organic extract was washed successively with saturated aqueous NaHCO~3~, water, and brine; dried; and concentrated in vacuo. Flash column chromatographic purification (SiO~2~, 100--200 mesh, 8% EtOAc in hexane as eluent) provided the corresponding MOM ether (1.51 g, 88%) as a colorless liquid: *R*~f~ = 0.60 (5% EtOAc/hexane); ^1^H NMR (CDCl~3~, 300 MHz) δ 7.34--7.24 (m, 5H), 5.90--5.76 (m, 1H), 5.07--4.96 (m, 2H), 4.77 (d, *J* = 6.9 Hz, 1H), 4.72--4.63 (m, 2H), 4.50 (d, *J* = 11.7 Hz, 1H), 3.74--3.69 (m, 1H), 3.46--3.37 (m, 4H), 2.31--2.19 (m, 1H), 2.14--2.03 (m, 1H), 1.79--1.67 (m, 1H), 1.59--1.42 (m, 3H), 1.35--1.25 (m, 6H), 0.87 (t, *J* = 6.9 Hz, 3H); ^13^C NMR (CDCl~3~, 75 MHz) δ 138.9, 138.6, 128.4, 127.9, 127.6, 114.9, 96.4, 81.2, 78.3, 72.2, 55.9, 32.0, 30.6, 30.3, 30.0, 25.9, 22.7, 14.2 ppm; IR (neat) ν~max~ 2930, 2859, 1718, 1272, 1096, 1026 cm^--1^; HRMS (ESI) *m*/*z* calcd for C~20~H~32~O~3~Na \[M + Na\]^+^ 343.2249, found 343.2246.

To a stirred solution of naphthalene (1.69 g, 13.2 mmol) in anhydrous THF (25 mL) under argon, small pieces of lithium metal (114 mg, 16.5 mmol) were added. The reaction mixture was then stirred at the ambient temperature for 2 h to form a dark green solution of lithium napthalenide. The reaction mixture was then cooled to −40 °C, and the above MOM-protected compound (1.06 g, 3.30 mmol) dissolved in 5 mL of anhydrous THF was cannulated into it. After being stirred at −40 °C for 30 min, the reaction mixture was quenched with the saturated aqueous solution of NH~4~Cl (5 mL) and extracted with EtOAc (3 × 30 mL). The combined organic layers were washed with water and brine and dried over Na~2~SO~4~, filtered, and concentrated under reduce pressure. The residue was purified by flash column chromatography (SiO~2~, 100--200 mesh, 8--18% EtOAc in hexane as eluent) to get compound **8** (620 mg, 82%) as a clear oil: *R*~f~ = 0.28 (10% EtOAc/hexane); \[α\]~D~^24^ = +7.9 (*c* 1.8, CHCl~3~); ^1^H NMR (CDCl~3~, 300 MHz) δ 5.88--5.74 (m, 1H), 5.06--4.96 (m, 2H), 4.73 (d, *J* = 6.6 Hz, 1H), 4.64 (d, *J* = 6.6 Hz, 1H), 3.63--3.59 (m, 1H), 3.53 (dt, *J* = 9.0, 3.0 Hz, 1H), 3.42 (s, 3H), 2.74 (d, *J* = 6.3 Hz, 1H), 2.30--2.20 (m, 1H), 2.18--2.01 (m, 1H), 1.75--1.61 (m, 1H), 1.59--1.47 (m, 2H), 1.46--1.39 (m, 2H), 1.37--1.25 (m, 5H), 0.89 (m, 3H); ^13^C NMR (CDCl~3~, 75 MHz) δ 138.3, 115.0, 97.3, 83.5, 73.1, 55.9, 32.0, 31.7, 30.2, 29.4, 26.0, 22.7, 14.1 ppm; HRMS (ESI) *m*/*z* calcd for C~13~H~26~O~3~Na \[M + Na\]^+^ 253.1780, found 253.1783.

### (4*S*,5*R*)-4-(Methoxymethoxy)dec-1-en-5-yl(2*S*,3*R*)-3-((*tert*-butyldimethylsilyl)oxy)-2-methylpent-4-enoate (**7**) {#sec4.1.3}

To a solution of acid **9** (300 mg, 1.28 mmol) and alcohol **8** (311 mg, 1.35 mmol) in anhydrous CH~2~Cl~2~ (10 mL) under argon, DMAP (62.5 mg, 0.51 mmol) and DIC (0.40 mL, 2.56 mmol) were added. The reaction mixture was stirred for 4 h and then diluted with CH~2~Cl~2~ (10 mL) before being quenched with H~2~O (5 mL). The organic layer was separated, and the aqueous phase was extracted with CH~2~Cl~2~ (2 × 20 mL). The combined organic phases were dried over Na~2~SO~4~, filtered, and concentrated under reduced pressure. Flash column chromatographic purification (SiO~2~, 230--400 mesh, 2--8% EtOAc in hexane as eluent) yielded ester **7** (443 mg, 79%) as a colorless liquid: *R*~f~ = 0.42 (5% EtOAc/hexane); ^1^H NMR (CDCl~3~, 300 MHz) δ 5.88--5.74 (m, 2H), 5.21--4.96 (m, 5H), 4.71 (d, *J* = 6.9 Hz, 1H), 4.57 (d, *J* = 6.9 Hz, 1H), 4.23 (t, *J* = 3.9 Hz, 1H), 3.64--3.59 (m, 1H), 3.37 (s, 3H), 2.51 (quintet, *J* = 6.9 Hz, 1H), 2.30--2.18 (m, 1H), 2.14--2.02 (m, 1H), 1.65--1.50 (m, 3H), 1.35--1.17 (m, 10H), 0.89--0.86 (m, 12H), 0.05 (s, 3H), 0.02 (s, 3H); ^13^C NMR (CDCl~3~, 75 MHz) δ 174.4, 139.5, 138.3, 115.9, 115.1, 96.1, 77.7, 75.6, 74.9, 55.9, 47.5, 31.8, 30.1, 29.8, 29.5, 25.9, 25.6, 22.6, 18.3, 14.1, 13.7, −4.0, −4.7 ppm; IR (neat) ν~max~ 2932, 2856, 1733, 1025 cm^--1^; HRMS (ESI) *m*/*z* calcd for C~25~H~48~O~5~NaSi \[M + Na\]^+^ 479.3169, found 479.3167.

### (6*R*,7*S*,14*S*,15*S*,*E*/*Z*)-7,14-Bis(methoxymethoxy)icos-10-ene-6,15-diyl(2*S*,2′*S*,3*R*,3′*R*)-bis(3-((*tert*-butyldimethylsilyl)oxy)-2-methylpent-4-enoate) (**13**) {#sec4.1.4}

A solution of ester **7** (60 mg, 0.13 mmol) in anhydrous and degassed CH~2~Cl~2~ (80 mL) was taken in a round-bottomed flask under argon fitted with a reflux condenser. The Grubbs second-generation metathesis catalyst (G-II, 11 mg, 0.013 mmol) was added, and the solution was refluxed for 13 h. The solvent was evaporated, and the resultant residue was directly loaded on a silica gel column. Flash column chromatography (SiO~2~, 100--200 mesh, 6% EtOAc in hexane as eluent) provided linear dimeric mixture **13** (43 mg, 37%) along with trace amount of lactone **12**.

Data for Compound **13** (**Mixture of Isomers**) {#sec4.2}
-------------------------------------------------

*R*~f~ = 0.43 (10% EtOAc/hexane); ^1^H NMR (CDCl~3~, 300 MHz) δ 5.88--5.77 (m, 1H), 5.40 (m, 1H), 5.19 (d, *J* = 17.1 Hz, 1H), 5.07 (d, *J* = 10.5 Hz, 1H), 4.96--4.94 (m, 1H), 4.71--4.65 (m, 1H), 4.59--4.56 (m, 1H), 4.22 (t, *J* = 7.2 Hz, 1H), 3.60--3.54 (m, 1H), 3.37 (m, 3H), 2.51 (quintet, *J* = 6.9 Hz, 1H), 2.22--2.03 (m, 2H), 1.64--1.45 (m, 4H), 1.33--1.17 (m, 9H), 0.88 (m, 12H), 0.05 (s, 3H), 0.02 (s, 3H); ^13^C NMR (CDCl~3~, 75 MHz) δ 174.4, 139.5, 132.6, 130.3, 128.2, 115.9, 96.1, 77.9, 75.6, 75.0, 56.0, 47.5, 31.8, 30.8, 29.8, 29.5, 29.0, 25.9, 25.6, 22.6, 18.3, 14.1, 13.7, −4.0, −4.7 ppm; HRMS (ESI) *m*/*z* calcd for C~48~H~92~O~10~ Si~2~Na \[M + Na\]^+^ 907.6127, found 907.6125.

Mass for Lactone **12** {#sec4.3}
-----------------------

HRMS (ESI) *m*/*z* calcd for C~23~H~44~O~5~SiNa \[M + Na\]^+^ 451.2856, found 451.2853.

### (4*S*,5*R*)-4-(Methoxymethoxy)dec-1-en-5-yl(2*S*,3*R*)-3-hydroxy-2-methylpent-4-enoate (**14**) {#sec4.3.1}

To a stirred solution of ester **7** (350 mg, 0.77 mmol) in anhydrous THF (5 mL) at 0 °C under argon, TBAF (1.15 mL, 1 M solution in THF, 1.15 mmol) was added. The reaction mixture was allowed to attain room temperature and stirred for 3 h prior to quenching with saturated aqueous NH~4~Cl solution (2 mL). The resultant mixture was extracted with EtOAc (3 × 20 mL), washed with water and brine, dried over Na~2~SO~4~, and concentrated in vacuo. Flash column chromatographic purification (SiO~2~, 100--200 mesh, 15% EtOAc in hexane as eluent) of the crude residue furnished compound **14** (239 mg, 91%) as a colourless liquid: *R*~f~ = 0.38 (10% EtOAc/hexane); ^1^H NMR (CDCl~3~, 300 MHz) δ 5.88--5.75 (m, 2H), 5.33 (dt, *J* = 17.1, 1.5 Hz, 1H), 5.21 (dt, *J* = 10.5, 1.5 Hz, 1H), 5.10--4.97 (m, 3H), 4.73 (d, *J* = 7.2 Hz, 1H), 4.57 (d, *J* = 7.2 Hz, 1H), 4.44--4.43 (m, 1H), 3.67--3.62 (m, 1H), 3.39 (s, 3H), 2.83 (d, *J* = 4.5 Hz, 1H), 2.68--2.60 (m, 1H), 2.30--2.22 (m, 1H), 2.15--2.04 (m, 1H), 1.70--1.50 (m, 4H), 1.47--1.26 (m, 6H), 1.18 (d, *J* = 7.2 Hz, 3H), 0.89--0.86 (m, 3H); ^13^C NMR (CDCl~3~, 75 MHz) δ 175.1, 138.1, 137.6, 116.3, 115.2, 96.1, 77.7, 75.4, 73.2, 56.0, 45.3, 31.7, 30.0, 29.8, 29.6, 25.5, 22.6, 14.0, 10.9 ppm; IR (neat) ν~max~ 3471, 2961, 2932, 2860, 1729, 1030 cm^--1^; HRMS (ESI) *m*/*z* calcd for C~19~H~34~O~5~Na \[M + Na\]^+^ 365.2304, found 365.2305.

### (3*S*,4*R*,9*S*,10*R*,*Z*)-10-Hexyl-4-hydroxy-9-(methoxymethoxy)-3-methyl-3,4,7,8,9,10-hexahydro-2*H*-oxecin-2-one (**15**) {#sec4.3.2}

To a solution of compound **14** (50 mg, 0.15 mmol) in anhydrous and degassed CH~2~Cl~2~ (60 mL), Grubbs second-generation metathesis catalyst (G-II, 12.7 mg, 0.015 mmol) was added, and the solution was refluxed for 2.5 h. The solvent was evaporated, and the residue was directly loaded on a silica gel column. Flash column chromatography (SiO~2~, 230--400 mesh, 7--24% EtOAc in hexane as eluent) afforded lactone **15** (21.1 mg, 46%) and cyclic dimeric products **16** (12.8 mg, 14%).

Data for Compound **15** {#sec4.4}
------------------------

*R*~f~ = 0.30 (10% EtOAc/hexane); ^1^H NMR (CDCl~3~, 300 MHz) δ 5.58 (td, *J* = 12.0, 3.0 Hz, 1H), 5.27 (t, *J* = 10.2 Hz, 1H), 5.05--4.99 (m, 1H), 4.63--4.57 (m, 3H), 3.62--3.57 (m, 1H), 3.36 (s, 3H), 2.59--2.42 (m, 2H), 2.09--1.98 (m, 2H), 1.62--1.52 (m, 3H), 1.38 (d, *J* = 6.9 Hz, 3H), 1.31--1.22 (m, 6H), 0.89--0.86 (m, 3H); ^13^C NMR (CDCl~3~, 75 MHz) δ 173.0, 133.5, 129.3, 94.8, 77.2, 75.0, 69.5, 55.8, 49.1, 31.7, 31.6, 30.5, 25.0, 22.6, 15.3, 14.1 ppm; IR (neat) ν~max~ 3458, 2957, 2930, 2857, 1737, 1030 cm^--1^; HRMS (ESI) *m*/*z* calcd for C~17~H~30~O~5~Na \[M + Na\]^+^ 337.1991, found 337.1994.

Mass for Compound **16** {#sec4.5}
------------------------

HRMS (ESI) *m*/*z* calcd for C~34~H~60~O~10~Na \[M + Na\]^+^ 651.4084, found 651.4083.

### (*R*)-6-Hydroxyundec-1-en-5-one (**20**) {#sec4.5.1}

To an ice-cold solution of compound **22** (1.00 g, 3.33 mmol) in anhydrous CH~2~Cl~2~ (10 mL) under argon, NaHCO~3~ (11.18 g, 13.3 mmol) and DMP (2.12 g, 5.00 mmol) were added sequentially. The reaction mixture was allowed to attain ambient temperature with constant stirring. After 3 h, the reaction mixture was quenched with saturated aqueous solution of Na~2~S~2~O~3~, diluted with Et~2~O (60 mL), and stirred for another 30 min until the two phases separated. The mixture was then transferred to a separating funnel, and the organic extract was washed with water and brine, dried over Na~2~SO~4~, and concentrated in vacuo. Purification of the crude residue by flash column chromatography (SiO~2~, 100--200 mesh, 5% EtOAc in hexane as eluent) furnished the corresponding ketone (940 mg, 95%) as a pale yellow liquid: *R*~f~ = 0.58 (5% EtOAc/hexane); \[α\]~D~^27^ = +24.2 (*c* 2.3, CHCl~3~); ^1^H NMR (CDCl~3~, 300 MHz) δ 5.87--5.74 (m, 1H), 5.06--4.94 (m, 2H), 4.00 (dd, *J* = 6.9, 5.4 Hz, 1H), 2.65--2.60 (m, 2H), 2.33--2.26 (m, 2H), 1.66--1.50 (m, 2H), 1.36--1.23 (m, 6H), 0.92--0.81 (m, 12H), 0.05 (s, 3H), 0.03 (s, 3H); ^13^C NMR (CDCl~3~, 75 MHz) δ 213.4, 137.5, 115.1, 78.9, 36.7, 35.0, 31.8, 27.3, 25.9, 24.5, 22.6, 18.2, 14.1, −4.7 ppm; IR (neat) ν~max~ 2955, 2929, 2858, 1717, 1092 cm^--1^; HRMS (ESI) *m*/*z* calcd for C~17~H~34~O~2~NaSi \[M + Na\]^+^ 321.2226, found 321.2228.

The above ketone (460 mg, 1.54 mmol) was dissolved in anhydrous THF (5 mL) under argon at 0 °C. TBAF (2.31 mL, 1 M solution in THF, 2.31 mmol) was added. The reaction mixture was warmed to room temperature and stirred further for 5 h prior to quenching with saturated aqueous NH~4~Cl solution (2 mL). The resultant mixture was extracted with EtOAc (3 × 15 mL), washed with water and brine, dried over Na~2~SO~4~, and concentrated in vacuo. Flash column chromatographic purification (SiO~2~, 100--200 mesh, 5% EtOAc in hexane as eluent) of the crude residue gave compound **20** (261 mg, 92%) as an oily liquid: *R*~f~ = 0.32 (5% EtOAc/hexane); \[α\]~D~^27^ = −38.4 (*c* 1.5, CHCl~3~); ^1^H NMR (CDCl~3~, 300 MHz) δ 5.85--5.71 (m, 1H), 5.07--4.96 (m, 2H), 4.17--4.12 (m, 1H), 3.45 (d, *J* = 5.1 Hz, 1H), 2.59--2.46 (m, 2H), 2.39--2.32 (m, 2H), 1.81--1.76 (m, 1H), 1.53--1.42 (m, 2H), 1.35--1.24 (m, 5H), 0.89--0.85 (m, 3H); ^13^C NMR (CDCl~3~, 75 MHz) δ 211.6, 136.6, 115.8, 76.6, 37.1, 33.8, 31.7, 27.6, 24.6, 22.5, 14.0 ppm; IR (neat) ν~max~ 3472, 2928, 2860, 1710, 1060 cm^--1^; HRMS (ESI) *m*/*z* calcd for C~11~H~20~O~2~Na \[M + Na\]^+^ 184.1463, found 184.1464.

### (2*S*,3*R*)-(*R*)-5-Oxoundec-1-en-6-yl-3-(methoxymethoxy)-2-methylpent-4-enoate (**18**) {#sec4.5.2}

Acid **19** (200 mg, 1.15 mmol) was dissolved in anhydrous toluene (5 mL) under argon at room temperature. Et~3~N (0.18 mL, 1.26 mmol) and 2,4,6-trichlorobenzoyl chloride (0.20 mL, 1.26 mmol) were added sequentially, and the reaction mixture was stirred for 30 min. DMAP (154 mg, 1.26 mmol) was then added. Compound **20** (185 mg, 1.0 mmol) dissolved in dry toluene (3 mL) was cannulated to the reaction mixture, and the mixture was stirred for 3 h prior to quenching with saturated aqueous solution of NH~4~Cl (1 mL). The reaction mixture was extracted with EtOAc (3 × 15 mL), washed with water and brine, dried over Na~2~SO~4~, and concentrated in vacuo. The product was purified by flash column chromatography (SiO~2~, 100--200 mesh, 3--9% EtOAc in hexane as eluent) to afford ester **18** (265 mg, 78%) as a colorless liquid: *R*~f~ = 0.40 (10% EtOAc/hexane); ^1^H NMR (CDCl~3~, 300 MHz) δ 5.84--5.70 (m, 2H), 5.35--5.23 (m, 2H), 5.04--4.94 (m, 3H), 4.68 (d, *J* = 6.9 Hz, 1H), 4.49 (d, *J* = 6.9 Hz, 1H), 4.21 (t, *J* = 8.7 Hz, 1H), 3.33 (s, 3H), 2.77--2.68 (m, 1H), 2.66--2.47 (m, 2H), 2.37--2.28 (m, 2H), 1.78--1.62 (m, 2H), 1.45--1.18 (m, 9H), 0.87 (m, 3H); ^13^C NMR (CDCl~3~, 75 MHz) δ 206.7, 173.7, 136.9, 135.6, 119.2, 115.4, 94.1, 79.3, 78.5, 55.8, 44.7, 37.9, 31.4, 30.5, 27.1, 24.9, 22.4, 14.0, 12.6 ppm; IR (neat) ν~max~ 2961, 2930, 2857, 1727, 1152, 1028 cm^--1^; HRMS (ESI) *m*/*z* calcd for C~19~H~32~O~5~Na \[M + Na\]^+^ 363.2148, found 363.2147.

### (3*S*,4*R*,10*R*,*Z*)-4-(Methoxymethoxy)-3-methyl-10-pentyl-3,4,7,8-tetrahydro-2*H*-oxecine-2,9(10*H*)-dione (**23**) {#sec4.5.3}

Following the same experimental procedure as described for the preparation of compound **15**, compound **18** (54 mg, 0.16 mmol) dissolved in anhydrous and degassed CH~2~Cl~2~ (80 mL) was treated with the Grubbs second-generation metathesis catalyst (G-II, 13.6 mg, 0.016 mmol) to yield compound **23** (26.4 mg, 51%) and dimeric products **24** (12.4 mg, 13%, purification 230--400 mesh, 7--18% EtOAc in hexane as eluent) as a brownish liquid.

Data for Compound **23** {#sec4.6}
------------------------

*R*~f~ = 0.50 (15% EtOAc/hexane); ^1^H NMR (CDCl~3~, 300 MHz) δ 5.65 (tdd, *J* = 12.0, 4.5, 1.5 Hz, 1H), 5.34 (t, *J* = 6.9 Hz, 1H), 5.12 (t, *J* = 6.9 Hz, 1H), 4.70 (d, *J* = 6.9 Hz, 1H), 4.60--4.51 (m, 2H), 3.41 (s, 3H), 3.05--2.90 (m, 1H), 2.84--2.76 (m, 1H), 2.66--2.56 (m, 1H), 2.39--2.30 (m, 1H), 2.23--2.15 (m, 1H), 1.84--1.77 (m, 2H), 1.41--1.22 (m, 9H), 0.91--0.86 (m, 3H); ^13^C NMR (CDCl~3~, 75 MHz) δ 206.0, 171.9, 133.3, 130.4, 94.3, 79.6, 73.0, 55.9, 46.9, 40.7, 31.3, 30.6, 24.6, 23.5, 22.5, 14.9, 14.0 ppm; IR (neat) ν~max~ 2929, 2858, 1747, 1710, 1031 cm^--1^; HRMS (ESI) *m*/*z* calcd for C~17~H~28~O~5~Na \[M + Na\]^+^ 335.1834, found 335.1833.

Mass for Compounds **24** {#sec4.7}
-------------------------

HRMS (ESI) *m*/*z* calcd for C~34~H~56~O~10~Na \[M + Na\]^+^ 647.3771, found 647.3773.

### (*S*)-3-((*tert*-Butyldimethylsilyl)oxy)pent-4-enoic acid (**27**) {#sec4.7.1}

To a solution of the above alcohol (520 g, 2.40 mmol) in CH~2~Cl~2~ and H~2~O (1:1, 10 mL), TEMPO (150 mg, 0.96 mmol) and BAIB (3.09 g, 9.60 mmol) were added. The reaction was continued for 3 h at the room temperature, and then the mixture was diluted with (10 mL) CH~2~Cl~2~. The organic layer was separated, and the aqueous layer was extracted with CH~2~Cl~2~ (2 × 15 mL). The combined organic layers were washed with saturated aqueous Na~2~S~2~O~3~ and brine, dried over Na~2~SO~4~, filtered, and the filtrate was concentrated under reduced pressure. Purification of the crude residue by column chromatography (SiO~2~, 100--200 mesh, 12--25% EtOAc in hexane as eluent) gave compound **27** (465 mg, 84%) as a liquid: *R*~f~ = 0.29 (20% EtOAc/hexane); \[α\]~D~^27^ = +2.9 (*c* 0.8, CHCl~3~); ^1^H NMR (CDCl~3~, 300 MHz) δ 5.90--5.79 (m, 1H), 5.25 (d, *J* = 17.1 Hz, 1H), 5.10 (d, *J* = 10.5 Hz, 1H), 4.58 (q, *J* = 6.0 Hz, 1H), 2.61--2.47 (m, 2H), 0.88 (s, 9H), 0.07 (s, 3H), 0.05 (s, 3H); ^13^C NMR (CDCl~3~, 75 MHz) δ 176.8, 139.8, 115.3, 70.7, 43.4, 25.8, 18.2, −4.2, −5.0 ppm; IR (neat) ν~max~ 2932, 2878, 1720, 1032 cm^--1^.

### (*S*)-(5*S*,6*R*)-5-(Methoxymethoxy)undec-1-en-6-yl-3-((*tert*-butyldimethylsilyl)oxy)pent-4-enoate (**26**) {#sec4.7.2}

Following the same experimental procedure as described for the preparation of compound **7**, acid **27** (250 mg, 1.09 mmol) and alcohol **8** (252 mg, 1.1 mmol) dissolved in anhydrous CH~2~Cl~2~ (10 mL) were treated with DMAP (48 mg, 0.40 mmol) and DIC (0.34 mL, 2.2 mmol) to yield ester **26** (389 mg, 81%, purification 230--400 mesh, 2--6% EtOAc in hexane as eluent) as a colorless liquid: *R*~f~ = 0.54 (5% EtOAc/hexane); ^1^H NMR (CDCl~3~, 300 MHz) δ 5.91--5.74 (m, 2H), 5.26--5.19 (m, 1H), 5.07--4.96 (m, 4H), 4.71 (d, *J* = 6.9 Hz, 1H), 4.59--4.57 (m, 2H), 3.62 (ddd, *J* = 8.4, 4.0, 2.7 Hz, 1H), 3.38 (s, 3H), 2.59 (dd, *J* = 14.97, 6.56 Hz, 1H), 2.47 (dd, *J* = 15.0, 6.6 Hz, 1H), 2.35--2.17 (m, 1H), 2.08 (m, 1H), 1.68--1.50 (m, 3H), 1.33--1.21 (m, 7H), 0.91--0.84 (m, 12H), 0.06 (s, 3H), 0.05 (s, 3H); ^13^C NMR (CDCl~3~, 75 MHz) δ 170.7, 140.3, 138.2, 115.1, 114.8, 96.1, 77.7, 75.2, 70.7, 55.9, 43.8, 31.8, 30.0, 30.0, 29.5, 25.9, 25.5, 22.6, 18.2, 14.1, −4.3, −4.8 ppm; IR (neat) ν~max~ 2929, 2857, 1736, 1032 cm^--1^; HRMS (ESI) *m*/*z* calcd for C~24~H~46~O~5~NaSi \[M + Na\]^+^ 465.3012, found 465.3014.

### (4*S*,9*S*,10*R*,*Z*)-4-((*tert*-Butyldimethylsilyl)oxy)-10-pentyl-9-(methoxymethoxy)-3,4,7,8,9,10-hexahydro-2*H*-oxecin-2-one (**29**) {#sec4.7.3}

Following the same experimental procedure as described for the preparation of compound **15**, compound **26** (66 mg, 0.15 mmol) dissolved in anhydrous and degassed CH~2~Cl~2~ (90 mL) was treated with the Grubbs second-generation metathesis catalyst (G-II, 12.7 mg, 0.015 mmol) to yield lactone **29** (24 mg, 39%, purification 100--200 mesh, 5--12% EtOAc in hexane as eluent) as a brownish liquid: *R*~f~ = 0.27 (5% EtOAc/hexane); ^1^H NMR (CDCl~3~, 300 MHz) δ 5.48 (td, *J* = 12.0, 3.6 Hz, 1H), 5.24 (t, *J* = 10.2 Hz, 1H), 5.08--4.95 (m, 2H), 4.58 (dd, *J* = 9.0, 6.9 Hz, 2H), 3.60 (m, 1H), 3.36 (m, 3H), 2.80 (dd, *J* = 15.3, 4.8 Hz, 1H), 2.59--2.45 (m, 1H), 2.43 (dd, *J* = 15.3, 11.1 Hz, 1H), 2.06--1.97 (m, 2H), 1.63--1.49 (m, 3H), 1.37--1.25 (m, 6H), 0.93--0.82 (m, 12H), 0.06 (s, 3H), 0.05 (s, 3H); ^13^C NMR (CDCl~3~, 75 MHz) δ 169.4, 131.3, 130.6, 94.6, 75.3, 65.2, 55.7, 44.4, 31.8, 31.5, 30.4, 25.9, 25.2, 24.9, 22.6, 18.3, 14.1, −4.3, −4.8 ppm; IR (neat) ν~max~ 2928, 2857, 1741, 1240, 1033 cm^--1^; HRMS (ESI) *m*/*z* calcd for C~22~H~42~O~5~NaSi \[M + Na\]^+^ 437.2699, found 437.2698.

### (2*S*,3*R*,*E*)-3-(Methoxymethoxy)-2-methyl-5-phenylpent-4-enoic Acid (**32**) {#sec4.7.4}

To a stirred solution of compound **33** (1.2 g, 3.28 mmol) in anhydrous CH~2~Cl~2~ (15 mL) under argon at 0 °C, DIPEA (1.14 mL, 6.56 mmol) and MOMCl (0.38 mL, 4.92 mmol) were added. The reaction mixture was allowed to attain room temperature and stirred for 3 h before quenching with water (4 mL). The organic layer was separated, and the aqueous part was extracted with EtOAc (2 × 30 mL). The extract was washed successively with saturated aqueous NaHCO~3~, water, and brine; dried; and concentrated in vacuo. Purification by flash column chromatography (SiO~2~, 100--200 mesh, 10% EtOAc in hexane as the eluent) provided the corresponding MOM-protected aldol adduct (1.21 g, 89%) as a viscous liquid: *R*~f~ = 0.60 (20% EtOAc/hexane); ^1^H NMR (CDCl~3~, 300 MHz) δ 7.37--7.29 (m, 2H), 7.28--7.18 (m, 8H), 6.58 (d, *J* = 16.0 Hz, 1H), 6.19 (dd, *J* = 16.0, 8.0 Hz, 1H), 4.73 (d, *J* = 6.8 Hz, 1H), 4.62--4.53 (m, 2H), 4.39 (t, *J* = 7.5 Hz, 1H), 4.24 (quintet, *J* = 6.8 Hz, 1H), 4.09 (dd, *J* = 9.0, 2.2 Hz, 1H), 4.01--3.93 (m, 1H), 3.38 (s, 3H), 3.26 (dd, *J* = 13.3, 3.2 Hz, 1H), 2.76 (dd, *J* = 13.3, 9.7 Hz, 1H), 1.34 (d, *J* = 6.8 Hz, 3H); ^13^C NMR (CDCl~3~, 75 MHz) δ 174.4, 153.4, 136.3, 135.4, 134.1, 129.5, 129.0, 128.7, 128.1, 127.4, 126.9, 126.7, 93.9, 78.4, 66.1, 55.8, 55.7, 42.6, 38.0, 13.3 ppm; IR (neat) ν~max~ 2937, 2886, 1776, 1697, 1380, 1208, 1023 cm^--1^; HRMS (ESI) *m*/*z* calcd for C~24~H~27~NO~5~Na \[M + Na\]^+^ 432.1787, found 432.1783.

To a stirred solution of the above compound (1.0 g, 2.44 mmol) in THF/water (3:1) (12 mL) at 0 °C, 30% aqueous H~2~O~2~ (14.64 mmol) and LiOH·H~2~O (205 mg, 4.88 mmol) were added sequentially. The reaction mixture was allowed to attain room temperature and stirred further for 8 h. The reaction mixture was neutralized using 1 N HCl and extracted with EtOAc (2 × 30 mL), washed with water and brine, dried over Na~2~SO~4~, and concentrated in vacuo. The organic layer was concentrated in reduced pressure, and the residue was purified by column chromatography (SiO~2~, 100--200 mesh, 15--24% EtOAc in hexane as eluent) to give acid **32** (495 mg, 81%) as a clear liquid: *R*~f~ = 0.18 (20% EtOAc/hexane); ^1^H NMR (CDCl~3~, 300 MHz) δ 7.40--7.34 (m, 2H), 7.35--7.21 (m, 3H), 6.62 (d, *J* = 15.6 Hz, 1H), 6.12 (dd, *J* = 15.9, 8.2 Hz, 1H), 4.75 (d, *J* = 6.8 Hz, 1H), 4.56 (d, *J* = 6.8 Hz, 1H), 4.49 (dd, *J* = 8.1, 5.6 Hz, 1H), 3.36 (s, 3H), 2.77 (m, 1H), 1.27 (d, *J* = 7.0 Hz, 3H); ^13^C NMR (CDCl~3~, 75 MHz) δ 179.2, 136.2, 134.8, 128.7, 128.2, 126.8, 126.0, 93.9, 77.6, 55.8, 44.9, 12.1 ppm; IR (neat) ν~max~ 2941, 2896, 1707, 1025 cm^--1^; HRMS (ESI) *m*/*z* calcd for C~14~H~18~O~4~Na \[M + Na\]^+^ 273.1103, found 273.1106.

### (2*S*,3*R*,*E*)-(5*S*,6*R*)-5-(Methoxymethoxy)undec-1-en-6-yl 3-(methoxymethoxy)-2-methyl-5-phenylpent-4-enoate (**31**) {#sec4.7.5}

Following the same experimental procedure as described for the preparation of compound **7**, compound **32** (300 mg, 1.20 mmol) and alcohol **8** (230 mg, 1.0 mmol) dissolved in anhydrous CH~2~Cl~2~ (8 mL) were treated with DMAP (58.6 mg, 0.48 mmol) and DIC (0.37 mL, 2.4 mmol) to yield ester **31** (383 mg, 83%, purification 100--200 mesh, 4--9% EtOAc in hexane as eluent) as a colorless liquid: *R*~f~ = 0.38 (10% EtOAc/hexane); ^1^H NMR (CDCl~3~, 300 MHz) δ 7.39--7.33 (m, 2H), 7.34--7.19 (m, 3H), 6.59 (d, *J* = 16.0 Hz, 1H), 6.13 (dd, *J* = 16.0, 8.3 Hz, 1H), 5.80 (tdd, *J* = 17.0, 10.2, 6.6 Hz, 1H), 5.06--4.95 (m, 3H), 4.75 (d, *J* = 6.6 Hz, 1H) 4.70 (d, *J* = 6.9 Hz, 1H), 4.55 (dd, *J* = 6.8, 1.3 Hz, 2H), 4.33 (t, *J* = 7.9 Hz, 1H), 3.65--3.56 (m, 1H), 3.39 (s, 3H), 3.55 (s, 3H), 2.75 (quintet, *J* = 7.01 Hz, 1H), 2.28--2.20 (m, 1H), 2.18--2.01 (m, 1H), 1.66--1.47 (m, 3H), 1.46--1.39 (m, 1H), 1.34--1.22 (m, 5H), 1.19--1.05 (m, 4H), 0.79 (t, *J* = 6.56 Hz, 3H); ^13^C NMR (CDCl~3~, 75 MHz) δ 173.8, 138.2, 136.4, 134.5, 128.6, 128.0, 126.8, 115.1, 96.0, 93.9, 78.2, 77.6, 76.7, 75.1, 55.8, 55.8, 45.9, 31.7, 30.0, 29.9, 29.6, 25.4, 22.4, 14.1, 13.8 ppm; IR (neat) ν~max~ 2957, 2932, 1731, 1025 cm^--1^; HRMS (ESI) *m*/*z* calcd for C~27~H~42~O~6~Na \[M + Na\]^+^ 485.2879, found 485.2877.

### (2*S*,2′*S*,3*R*,3′*R*,4*E*,4′*E*)-(6*R*,7*S*,14*S*,15*S*,*E*/*Z*)-7,14-Bis(methoxymethoxy)icos-10-ene-6,15-diyl Bis(3-(methoxymethoxy)-2-methyl-5-phenylpent-4-enoate) (**34**) {#sec4.7.6}

Following the same experimental procedure as described for the preparation of compound **15**, compound **31** (55 mg, 0.12 mmol) dissolved in anhydrous and degassed CH~2~Cl~2~ (60 mL) was treated with the Grubbs second-generation metathesis catalyst (G-II, 10 mg, 0.012 mmol) to yield compounds **34** (41 mg, 38%, purification 100--200 mesh, 25% EtOAc in hexane as eluent) as a light brick red liquid: *R*~f~ = 0.21 (30% EtOAc/hexane); (mixture of isomers) ^1^H NMR (CDCl~3~, 300 MHz) δ 7.38--7.20 (m, 5H), 6.59 (d, *J* = 15.9 Hz, 1H), 6.12 (dd, *J* = 15.9, 8.4 Hz, 1H), 5.49--5.40 (m, 1H), 4.98--4.93 (m, 1H), 4.76--4.64 (m, 2H), 4.57--4.53 (m, 2H), 4.33 (t, *J* = 7.8 Hz, 1H), 3.68--3.57 (m, 1H), 3.89--3.33 (m, 6H), 2.74 (quintet, *J* = 4.2 Hz, 1H), 2.30--2.15 (m, 2H), 1.58--1.41 (m, 3H), 1.35--1.25 (m, 5H), 1.25--1.08 (m, 5H), 0.84--0.76 (m, 3H); ^13^C NMR (CDCl~3~, 75 MHz) δ 173.8, 173.7, 136.3, 134.5, 132.6, 130.3, 128.6, 128.0, 126.7, 96.0, 95.9, 93.9, 78.2, 77.8, 77.7, 75.1, 75.0, 55.8, 55.7, 55.6, 45.8, 34.2, 31.6, 30.6, 30.4, 29.5, 29.3, 28.9, 25.4, 25.3, 22.4, 14.0, 13.7 ppm; HRMS (ESI) *m*/*z* calcd for C~52~H~80~O~12~Na \[M + Na\]^+^ 919.5547, found 919.5543.

### (5*S*,6*R*,*E*)-5-(Methoxymethoxy)-1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)undec-1-en-6-ol (**36**) {#sec4.7.7}

A solution of vinyl pinacol boronate **37** (0.11 mL, 0.65 mmol) and olefin **8** (100 mg, 0.43 mmol) in anhydrous and degassed CH~2~Cl~2~ (5 mL) was taken in a round-bottomed flask under argon equipped with a reflux condenser. The G-II catalyst (18.6 mg, 0.022 mmol) was added. The brick red solution was refluxed for 6 h. The mixture was then concentrated in vacuo, and the resultant residue was purified by silica gel chromatography (SiO~2~, 230--400 mesh, 8--17% EtOAc in hexane as eluent) to afford compound **36** (99 mg, 64%) as a light brown liquid: *R*~f~ = 0.32 (20% EtOAc/hexane); ^1^H NMR (CDCl~3~, 300 MHz) δ 6.67--6.56 (m, 1H), 5.45 (d, *J* = 18.0 Hz, 1H), 4.72 (d, *J* = 6.6 Hz, 1H), 4.62 (d, *J* = 6.6 Hz, 1H), 3.61--3.47 (m, 2H), 3.41 (m, 3H), 2.75 (m, 1H), 2.39--2.28 (m, 1H), 2.23--2.11 (m, 1H), 1.73--1.66 (m, 1H), 1.58--1.50 (m, 2H), 1.36--0.87 (m, 19H), 0.89 (m, 3H); ^13^C NMR (CDCl~3~, 75 MHz) δ 153.7, 97.4, 83.6, 83.2, 73.1, 55.9, 32.1, 32.0, 31.7, 28.9, 25.9, 24.8, 24.8, 22.7, 14.1 ppm; HRMS (ESI) *m*/*z* calcd for C~19~H~37~BO~5~Na \[M + Na\]^+^ 379.2635, found 379.2633.

### (5*S*,6*R*,*E*)-5-(Methoxymethoxy)-1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)undec-1-en-6-yl(2*S*,3*R*)-3-(methoxymethoxy)-2-methylpent-4-enoate (**35**) {#sec4.7.8}

Following the same experimental procedure as described for the preparation of compound **7**, acid **19** (135 mg, 0.84 mmol) and alcohol **36** (285 mg, 0.80 mmol) dissolved in anhydrous CH~2~Cl~2~ (7 mL) were treated with DMAP (41 mg, 0.34 mmol) and DIC (0.26 mL, 1.68 mmol) to yield ester **35** (196 mg, 49%, purification 100--200 mesh, 3--8% EtOAc in hexane as eluent) as a colorless liquid: *R*~f~ = 0.67 (20% EtOAc/hexane); ^1^H NMR (CDCl~3~, 300 MHz) δ 6.63 (dt, *J* = 18.0, 6.0 Hz, 1H), 5.76 (m, 1H), 5.46 (d, *J* = 15.0 Hz, 1H), 5.34--5.23 (m, 2H), 5.00--4.97 (m, 1H), 4.72--4.67 (m, 2H), 4.58--4.53 (m, 2H), 4.18 (t, *J* = 7.5 Hz, 1H), 3.62--3.60 (m, 1H), 3.41--3.29 (m, 6H), 2.69--2.59 (m, 1H), 2.42--2.30 (m, 1H), 2.23--2.11 (m, 1H), 1.65--1.59 (m, 4H), 1.35--1.19 (m, 21H), 0.87 (m, 3H); ^13^C NMR (CDCl~3~, 75 MHz) δ 173.8, 153.7, 135.9, 119.2, 96.1, 94.2, 83.2, 78.6, 75.0, 77.8, 75.0, 55.9, 55.8, 45.4, 32.0, 31.8, 29.6, 29.3, 25.4, 24.9, 22.6, 14.1, 13.2 ppm; IR (neat) ν~max~ 2929, 1732, 1694, 1032 cm^--1^; HRMS (ESI) *m*/*z* calcd for C~27~H~49~BO~8~Na \[M + Na\]^+^ 535.3423, found 535.3425.

### (3*S*,4*R*,9*S*,10*R*,*Z*)-4,9-Bis(methoxymethoxy)-3-methyl-10-pentyl-3,4,7,8,9,10-hexahydro-2*H*-oxecin-2-one (**38**) {#sec4.7.9}

Following the same experimental procedure as described for the preparation of compound **15**, compound **35** (72 mg, 0.14 mmol) dissolved in anhydrous and degassed CH~2~Cl~2~ (74 mL) was treated with the Grubbs second-generation metathesis catalyst (G-II, 6 mg, 0.007 mmol) to yield compound **38** (34 mg, 68%, purification 100--200 mesh, 6% EtOAc in hexane as eluent) as a brownish liquid: *R*~f~ = 0.33 (10% EtOAc/hexane); ^1^ H NMR (300 MHz, CDCl~3~) δ 5.71 (dt, *J* = 11.4, 3.0 Hz, 1H), 5.15 (t, *J* = 9.9 Hz, 1H), 5.05--4.99 (m, 1H), 4.71 (d, *J* = 6.9 Hz, 1H), 4.60 (q, *J* = 6.8 Hz, 2H), 4.51 (m, 2H), 3.62 (bt, *J* = 5.2 Hz, 1H), 3.40 (s, 3H), 3.36 (s, 3H), 2.61--2.51 (m, 2H), 2.09--2.00 (m, 2H), 1.62--1.49 (m, 3H), 1.38--1.23 (m, 9H), 0.90 (m, 3H); ^13^C NMR (CDCl~3~, 75 MHz) δ 172.9, 135.9, 127.2, 94.8, 94.1, 77.4, 75.1, 72.7, 55.8, 47.6, 31.7, 31.5, 30.5, 25.0, 24.9, 22.6, 15.5, 14.1; HRMS (ESI) *m*/*z* calcd for C~19~H~34~O~6~Na \[M + Na\]^+^ 381.2253, found 381.2255.

### 3-(2,2-Dimethyl-5-pentyl-1,3-dioxolan-4-yl)propan-1-ol (**43**, **43a**) {#sec4.7.10}

To an ice-cold solution of compound **42** (5.0 g, 32.0 mmol) in a mixture of THF (15 mL), ^*t*^BuOH (15 mL), and water (3 mL), OsO~4~ (2% solution in ^*t*^BuOH, 2.5 mL) and NMO (7.5 g, 64.0 mmol) were added, and the reaction mixture was stirred for 1 h at the same temperature. Next, the reaction mixture was allowed to warm to room temperature and stirred for another 6 h. It was then quenched with a solution of Na~2~SO~3~. The solvent was removed in a rotary evaporator, and the residue was extracted with EtOAc (3 × 50 mL). The combined organic extracts were washed with water and brine, dried (Na~2~SO~4~), and concentrated in vacuo to give the corresponding triol as a white solid, which was taken directly to the next reaction without further purification or characterization.

To an ice-cold solution of the above triol in anhydrous CH~2~Cl~2~ (50 mL) were added 2,2-DMP (10 mL) and CSA (75 mg, 0.32 mmol). The solid was insoluble initially. However, it dissolved slowly with the progress of the reaction. After 3 h, the reaction was quenched with a saturated solution of NaHCO~3~. The reaction mixture was extracted with CH~2~Cl~2~ (2 × 50 mL), washed with brine, dried (Na~2~SO~4~), and concentrated in vacuo. The resultant residue was purified by column chromatography (SiO~2~, 100--200 mesh, 15--28% EtOAc in hexane as eluent) to afford a mixture of compounds **43** and **43a** (12.4 g, 84%) as a colorless liquid: *R*~f~ = 0.25 (20% EtOAc/hexane); ^1^H NMR (500 MHz, CDCl~3~) δ 4.06--4.04 (m, 2H), 3.70--3.66 (m, 2H), 2.20 (bs, 1H), 1.75--1.55 (m, 2H), 1.53--1.36 (m, 7H), 1.33--1.24 (m, 9H), 0.88 (m, 3H); ^13^C NMR (100 MHz, CDCl~3~) δ 107.6, 78.3, 78.2, 62.9, 32.0, 29.9, 29.8, 28.6, 26.8, 26.0, 22.7, 14.1 ppm; IR (neat) ν~max~ 3407, 2933, 1218, 1029 cm^--1^; HRMS (ESI) *m*/*z* calcd for C~13~H~26~O~3~Na \[M + Na\]^+^ 253.1780, found 253.1782.

### (*E*)-5-(2,2-Dimethyl-5-pentyl-1,3-dioxolan-4-yl)pent-2-en-1-ol (**41**, **41a**) {#sec4.7.11}

To a stirred solution of (COCl)~2~ (1.79 mL, 20.93 mmol) in anhydrous CH~2~Cl~2~ (20 mL) under argon at −78 °C, anhydrous DMSO (3.05 mL, 41.85 mmol) was added dropwise. After 15 min, compounds **43** and **43a** (3.21 g, 13.95 mmol) dissolved in anhydrous CH~2~Cl~2~ (13 mL) were cannulated into the reaction mixture and the reaction mixture was stirred for 30 min at −78 °C. Anhydrous Et~3~N (9.70 mL, 69.75 mmol) was then added, and the reaction mixture was stirred for another 30 min at the same temperature. The reaction mixture was then allowed to warm to 0 °C and then quenched with a saturated aqueous solution of NH~4~Cl (5 mL). The reaction mixture was extracted with CH~2~Cl~2~ (3 × 50 mL), washed with water and brine, dried over Na~2~SO~4~, and concentrated in vacuum. Flash chromatography with a short pad of silica gave the corresponding aldehyde, which was used for the next step without further purification and characterizations.

The above aldehyde was dissolved in dry toluene, and ethyl(triphenylphosphoranylidene)acetate (9.7 g, 27.9 mmol) was added. The reaction was continued for 6 h at 80 °C. The mixture was then cooled, and toluene was evaporated in vacuum. The resultant residue was purified by flash column chromatography (SiO~2~, 100--200 mesh, 5--12% EtOAc in hexane as eluent) to yield the corresponding α,β-unsaturated ester (3.39 g, 81%) as a colored liquid: *R*~f~ = 0.64 (20% EtOAc/hexane); (mixture of isomers) ^1^H NMR (500 MHz, CDCl~3~) δ 6.97 (m, 1H), 5.83 (d, *J* = 15.5 Hz, 1H), 4.15 (q, *J* = 7.0 Hz, 2H), 4.04--3.99 (m, 2H), 2.45--2.40 (m, 1H), 2.25--2.22 (m, 1H), 1.64--1.60 (m, 1H), 1.51--1.45 (m, 3H), 1.44--1.36 (m, 4H), 1.37--1.25 (m, 11H), 0.87 (m, 3H); ^13^C NMR (125 MHz, CDCl~3~) δ 166.7, 148.5, 121.8, 107.6, 78.0, 77.4, 60.3, 32.0, 29.6, 28.9, 28.7, 28.6, 26.1, 26.0, 22.6, 14.3, 14.1 ppm; IR (neat) ν~max~ 2935, 1722, 1654, 1217 cm^--1^; HRMS (ESI) *m*/*z* calcd for C~17~H~30~O~4~Na \[M + Na\]^+^ 321.2042, found 321.2044.

To a cooled solution (−78 °C) of the above ester (3.89 g, 13.05 mmol) in anhydrous CH~2~Cl~2~ (15 mL) under argon, DIBAL-H (1.0 M in toluene, 27.40 mL, 27.40 mmol) was added dropwise. The reaction mixture was stirred for another 30 min before quenching it with MeOH (8 mL). The reaction mixture was diluted with Et~2~O (60 mL), a saturated solution of sodium potassium tartrate (20 mL) was added, and the mixture was stirred further for 1 h until the two layers separated well. The solvent was removed, and the aqueous part was extracted with Et~2~O (2 × 50 mL), washed with water and brine, dried over Na~2~SO~4~, and concentrated in vacuo. Flash column chromatography (SiO~2~, 100--200 mesh, 25% EtOAc in hexane as eluent) of the crude residue afforded an inseparable mixture of allylic alcohols **41** and **41a** (2.95 g, 88%) as a colorless oil: *R*~f~ = 0.29 (20% EtOAc/hexane); (mixture of isomers) ^1^H NMR (500 MHz, CDCl~3~) δ 5.69--5.60 (m, 2H), 4.05--3.96 (m, 4H), 2.25--2.19 (m, 1H), 2.08--1.95 (m, 2H), 1.59--1.46 (m, 3H), 1.45--1.41 (m, 4H), 1.39--1.21 (m, 9H), 0.85 (t, *J* = 6.5 Hz, 3H); ^13^C NMR (100 MHz, CDCl~3~) δ 132.4, 129.6, 107.5, 78.1, 63.7, 32.0, 29.7, 29.5, 28.9, 28.7, 26.1, 26.0, 22.8, 22.6, 14.1 ppm; IR (neat) ν~max~ 3351, 2936, 1455, 1217 cm^--1^; HRMS (ESI) *m*/*z* calcd for C~15~H~28~O~3~Na \[M + Na\]^+^ 279.1936, found 279.1939.

### (4*S*)-4-Benzyl-3-((2*S*,3*R*,*E*)-3-((*tert*-butyldimethylsilyl)oxy)-7-(2,2-dimethyl-5-pentyl-1,3-dioxolan-4-yl)-2-methylhept-4-enoyl)oxazolidin-2-one (**40**, **40a**) {#sec4.7.12}

Following a similar procedure as that of the above Swern oxidation, the mixture of compounds **41**and **41a** (2.01 g, 7.80 mmol) was converted to the corresponding aldehyde, which was used for the next step without further purification and characterizations.

To a dry round-bottomed flask under argon, (*S*)-4-benzyl-3-propionyloxazolidin-2-one (1.82 g, 7.80 mmol) and anhydrous 40 mL CH~2~Cl~2~ were added. After cooling to 0 °C, TiCl~4~ (0.94 mL, 8.58 mmol) was added dropwise and the solution was allowed to stir for 15 min. DIPEA (1.63 mL, 9.36 mmol) was added dropwise to the reaction mixture, and the solution was stirred for 40 min. 1-Methyl-2-pyrrolidinone (0.75 mL, 7.80 mmol) was added at 0 °C, and the mixture was stirred for an additional 15 min. The aldehyde from the previous step was dissolved in anhydrous CH~2~Cl~2~ (10 mL) and cannulated directly to the in situ generated enolate. The reaction mixture was stirred further for 1 h at the same temperature and finally quenched with a saturated aqueous solution of NH~4~Cl. The organic layer was separated, and the aqueous layer was extracted with CH~2~Cl~2~ (2 × 30 mL). The combined organic layers were dried over Na~2~SO~4~, filtered, and concentrated. Flash column chromatography of the crude residue (SiO~2~, 230--400, 18--35% EtOAc in hexane as eluent) furnished an inseparable mixture of corresponding diastereomers (3.01 g, 78.6% yield over two steps) as a gummy liquid: *R*~f~ = 0.33 (25% EtOAc/hexane); (mixture of isomers) ^1^HNMR (300 MHz, CDCl~3~) δ 7.36--7.19 (m, 5H), 5.83--5.74 (m, 1H), 5.52 (dd, *J* = 15.3, 6.0 Hz, 1H), 4.74--4.66 (m, 1H), 4.46--4.43 (m, 1H), 4.25--4.16 (m, 2H), 4.03--3.98 (m, 2H), 3.90--3.82 (m, 1H), 3.25 (dd, *J* = 13.3, 3.5 Hz, 1H), 2.87--2.75 (m, 2H), 2.31--2.22 (m, 1H), 2.16--2.06 (m, 1H), 1.53--1.44 (m, 3H), 1.42--1.37 (m, 4H), 1.32--1.23 (m, 12H), 0.91--0.87 (m, 3H); ^13^C NMR (75 MHz, CDCl~3~) δ 176.7, 153.2, 135.1, 132.6, 129.5, 129.0, 127.5, 107.4, 78.1, 77.4, 72.6, 66.3, 55.2, 42.9, 37.9, 31.9, 29.7, 29.4, 28.9, 28.7, 26.1, 26.0, 22.6, 14.1, 11.3 ppm; IR (neat) ν~max~ 3472, 2934, 2860, 1781, 1698, 1455, 1380, 1217, 771 cm^--1^; HRMS (ESI) *m*/*z* calcd for C~28~H~41~NO~6~Na \[M + Na\]^+^ 510.2832, found 510.2834.

To an ice-cold solution of the above aldol adducts (2.73 g, 5.61 mmol) in anhydrous CH~2~Cl~2~ (20 mL), 2,6-lutidine (1.53 mL, 14.02 mmol) and TBSOTf (1.54 mL, 6.73 mmol) were added sequentially, and the reaction mixture was stirred for 30 min at the same temperature before quenching with a saturated aqueous solution of NaHCO~3.~ The organic layer was separated, and the aqueous layer was extracted with CH~2~Cl~2~ (2 × 30 mL). The combined organic extracts were washed with aqueous CuSO~4~, water, and brine, dried (Na~2~SO~4~), filtered, and concentrated in vacuo. Purification of the crude residue by column chromatography (SiO~2~, 100--200 mesh, 10% EtOAc in hexane as eluent) furnished compounds **40** and **40a** (3.05 g, 91%) as a gummy liquid: *R*~f~ = 0.39 (10% EtOAc/hexane); (mixture of isomers) ^1^H NMR (300 MHz, CDCl~3~) δ 7.33--7.20 (m, 5H), 5.66--5.58 (m, 1H), 5.50 (dd, *J* = 15.9, 6.6 Hz, 1H), 4.62--4.55 (m, 1H), 4.29 (t, *J* = 6.6 Hz, 1H), 4.18--4.09 (m, 2H), 4.03--3.96 (m, 3H), 3.27 (dd, *J* = 13.5, 3.0 Hz, 1H), 2.77 (dd, *J* = 13.5, 9.6 Hz, 1H), 2.26--2.19 (m, 1H), 2.11--1.99 (m, 1H), 1.54--1.38 (m, 7H), 1.36--1.24 (m, 9H), 1.20 (d, *J* = 6.9 Hz, 3H), 0.92--0.86 (m, 12H), 0.02 (s, 3H), 0.00 (s, 3H); ^13^C NMR (75 MHz, CDCl~3~) δ 174.9, 153.3, 135.5, 131.7, 131.7, 131.6, 131.6, 129.5, 129.0, 127.4, 107.4, 78.0, 77.3, 75.1, 66.0, 55.7, 44.4, 37.9, 32.0, 29.7, 29.5,29.4, 28.8, 28.7, 26.1, 26.0, 25.9, 25.7, 22.7, 18.2, 14.1, 12.7, −4.0, −4.8 ppm; IR (neat) ν~max~ 2932, 2858, 1781, 1698, 1379, 1217, 774 cm^--1^; HRMS (ESI) *m*/*z* calcd for C~34~H~55~NO~6~Na \[M + Na\]^+^ 624.3696, found 624.3697.

### (2*S*,3*R*,*E*)-3-((*tert*-Butyldimethylsilyl)oxy)-8,9-dihydroxy-2-methyltetradec-4-enoic acid (**39**, **39a**) {#sec4.7.13}

To a stirred THF/water (3:1) (12 mL) solution of compounds **40** and **40a** (2.24 g, 3.72 mmol) at 0 °C, 30% aqueous H~2~O~2~ (22.32 mmol) and LiOH·H~2~O (312 mg, 7.44 mmol) were added sequentially, and the reaction mixture was allowed to attain room temperature. After 10 h, the reaction mixture was neutralized using 1 N HCl and extracted with EtOAc (3 × 50 mL), washed with water and brine, dried over Na~2~SO~4~, and concentrated in vacuo. The organic layer was concentrated in reduced pressure, and the residue was purified by column chromatography (SiO~2~, 100--200 mesh, 12--18% EtOAc in hexane as eluent) to provide a mixture of corresponding acids (1.33 g, 81%) as a clear liquid: *R*~f~ = 0.41 (20% EtOAc/hexane); (mixture of isomers) ^1^H NMR (300 MHz, CDCl~3~) δ 5.70--5.62 (m, 1H), 5.44 (dd, *J* = 15.3, 7.2 Hz, 1H), 4.36--4.32 (m, 1H), 4.02--3.97 (m, 2H), 2.61--2.52 (m, 1H), 2.31--2.17 (m, 1H), 2.15--2.00 (m, 1H), 1.60--1.45 (m, 3H), 1.44--1.38 (m, 4H), 1.39--1.22 (m, 9H), 1.11 (d, *J* = 6.9 Hz, 3H), 0.96--0.82 (m, 12H), 0.06 (s, 3H), 0.03 (s, 3H); ^13^C NMR (75 MHz, CDCl~3~) δ 178.1, 132.9, 130.1, 130.0, 107.5, 78.1, 77.3, 76.7, 75.1, 46.2, 32.0, 29.7, 29.3, 28.8, 28.8, 28.7, 26.1, 26.0, 25.9, 25.8, 22.7, 18.1, 14.1, 11.6, −4.0, −4.9 ppm; IR (neat) ν~max~ 2954, 2859, 1712, 1250, 1062, 775 cm^--1^; HRMS (ESI) *m*/*z* calcd for C~24~H~46~O~5~SiNa \[M + Na\]^+^ 465.3012, found 465.3011.

To a solution of the above acid (920 mg, 2.08 mmol) in CH~3~CN (10 mL), Zn (NO~3~)~2~·6H~2~O (787 mg, 4.16 mmol) was added, and the reaction mixture was stirred for 6 h. The solvent was evaporated, and the oily residue was diluted with CH~2~Cl~2~ (20 mL). The organic layer was washed with water and brine and dried over Na~2~SO~4~. The solvent was evaporated, and the resultant residue was purified by column chromatography (SiO~2~, 100--200, 2--5% MeOH in CH~2~Cl~2~ as eluent) to afford seco acids **39** and **39a** (602 mg, 72%, borsm): *R*~f~ = 0.12 (5% CH~2~Cl~2~/MeOH); (mixture of isomers) ^1^H NMR (500 MHz, CDCl~3~) δ 5.61--5.54 (m, 1H), 5.43 (dd, *J* = 15.5, 8.0 Hz, 1H), 4.18--4.12 (m, 1H), 3.58--3.55 (m, 2H), 2.54--2.51 (m, 1H), 2.22--2.12 (m, 2H), 1.51--1.49 (m, 2H), 1.44--1.38 (m, 2H), 1.30--1.23 (m, 6H), 1.16--1.50 (m, 3H), 0.89--0.87 (m, 12H), 0.06 (s, 3H), 0.03 (s, 3H) ppm; ^13^C NMR (75 MHz, CDCl~3~) δ177.6, 133.1, 133.0, 131.1, 130.6, 75.9, 75.7, 75.1, 74.7, 73.9, 73.5, 47.2, 47.1, 32.0, 30.7, 30.6, 28.6, 28.4, 25.9, 25.8, 22.7, 18.2, 14.1, 13.2, 13.1, −3.8, −3.9, −4.8, −4.8 ppm; IR (neat) ν~max~ 3403, 2933, 1713, 1219, 772 cm^--1^; HRMS (ESI) *m*/*z* calcd for C~21~H~42~O~5~SiNa \[M + Na\]^+^ 425.2699, found 425.2697.

### (3*S*,4*R*,9*R*,10*S*,*E*)-4,9-Dihydroxy-3-methyl-10-pentyl-3,4,7,8,9,10-hexahydro-2*H*-oxecin-2-one (**45**) {#sec4.7.14}

2,4,6-Trichlorobenzoyl chloride (0.11 mL, 0.71 mmol) was added to a stirred solution of the mixture of seco acids **39** and **39a** (55 mg, 0.14 mmol) and Et~3~N (0.19 mL, 1.40 mmol) in anhydrous THF (7 mL) under argon at room temperature. After stirred the reaction mixture for 6 h, the resultant Et~3~N·HCl salt was filtered off quickly and the filtrate was concentrated under reduced pressure. The mixed anhydride thus obtained was dissolved in anhydrous toluene (20 mL) and added slowly via a syringe pump over 8 h to a stirred solution of DMAP (87 mg, 0.71 mmol) in anhydrous toluene (100 mL) at 80 °C. The syringe was rinsed with another 20 mL of dry toluene, which was added over 2 h at the same temperature. The reaction mixture was then allowed to attain room temperature and stirred further for 12 h. The reaction mixture was quenched with saturated aqueous NaHCO~3~ (5 mL) solution. The toluene layer was separated, and the aqueous layer was extracted with EtOAc (2 × 15 mL). The organic extracts were combined, washed with water and brine, dried (Na~2~SO~4~), and concentrated in vacuo. The attempt to purify the crude residue by column chromatography (SiO~2~, 230--400 mesh, 10--15% EtOAc in hexane as eluent) resulted in a complex inseparable mixture of compounds (14 mg), which was taken for the next step without further characterizations.

To an ice-cold solution of the above mixture (14 mg) in anhydrous THF (2 mL), TBAF (1.0 M solution in THF, 0.15 mL) was added. The reaction mixture was then stirred for 3 h at the same temperature prior to quenching with saturated NH~4~Cl solution (1 mL). The mixture was extracted with EtOAc (2 × 15 mL), washed with water and brine, dried (Na~2~SO~4~), filtered, and concentrated in vacuo. Purification of the crude residue by column chromatography (SiO~2~, 100--200 mesh, 30% EtOAc in hexane as eluent) yielded lactone **45** (4 mg, 22%, based on a single isomer) as a colorless oil: *R*~f~ = 0.45 (40% EtOAc/hexane); \[α\]^29^~D~ = +6.13 (*c* 0.2, CHCl~3~); ^1^H NMR (500 MHz, CDCl~3~) δ 5.50 (dd, *J* = 16.0, 8.0 Hz, 1H), 5.47--5.41 (m, 1H), 4.77 (ddd, *J* = 11.0, 7.5, 4.0 Hz, 1H), 3.93 (t, *J* = 9.0 Hz, 1H), 3.65 (m, 1H), 2.50 (dq, *J* = 9.0, 6.5 Hz, 1H), 2.31--2.27 (m, 1H), 2.11--2.06 (m, 1H), 1.98--1.93 (m, 1H), 1.84--1.79 (m, 2H), 1.78--1.75 (m, 1H), 1.71--1.66 (m, 1H), 1.56 (m, 1H, merged with H~2~O), 1.43--1.22 (m, 9H), 0.87 (m, 3H); ^13^C NMR (75 MHz, CDCl~3~) 174.7, 133.6, 131.8, 78.1, 77.3, 74.2, 49.4, 37.8, 32.2, 31.9, 28.4, 24.6, 22.6, 14.1, 13.2 ppm; IR (neat) ν~max~ 3359, 3198, 2987, 2945, 2852, 1710, 1665, 1634, 1463 cm^--1^; HRMS (ESI) *m*/*z* calcd for C~15~H~26~O~4~Na \[M + Na\]^+^ 293.1729, found 293.1727.

### 3-((4*S*,5*R*)-2,2-Dimethyl-5-pentyl-1,3-dioxolan-4-yl)propan-1-ol (**43**) {#sec4.7.15}

To a stirred solution of (COCl)~2~ (4.15 mL, 48.20 mmol) in anhydrous CH~2~Cl~2~ (80 mL) under argon at −78 °C, DMSO (6.85 mL, 96.40 mmol) was added dropwise. After 15 min, alcohol **46** (6.51 g, 32.15 mmol) dissolved in anhydrous CH~2~Cl~2~ (25 mL) was cannulated into the reaction mixture, which was stirred for 30 min at the same temperature. Et~3~N (22.40 mL, 160.66 mmol) was added, and the mixture was stirred for another 30 min at the same temperature. The reaction mixture was then warmed slowly to room temperature. The complete formation of the corresponding aldehyde was confirmed by TLC. Next, ethyl(triphenylphosphoranylidene)acetate (11.19 g, 32.13 mmol) was added into the reaction mixture and the reaction mixture was stirred for 10 h at the same temperature. After completion of the reaction, the solvent was evaporated under reduced pressure. Flash column chromatography (SiO~2~, 100--200 mesh, 8% EtOAc in hexane as eluent) of the residue furnished the corresponding α,β-unsaturated ester (7.01 g, 80.5%) as a colored liquid: *R*~f~ = 0.65 (20% EtOAc/hexane); \[α\]~D~^27^ = −6.13 (*c* 3.3, CHCl~3~); ^1^H NMR (500 MHz, CDCl~3~) δ 6.81 (dd, *J* = 16.0, 6.0 Hz, 1H), 6.03 (d, *J* = 16.0 Hz, 1H), 4.60 (m, 1H), 4.20--4.16 (m, 3H), 1.48--1.43 (m, 5H), 1.37--1.23 (m, 12H), 0.87--0.84 (m, 3H); ^13^C NMR (125 MHz, CDCl~3~) δ 166.1, 143.9, 123.0, 108.8, 78.5, 77.5, 60.5, 31.7, 30.5, 28.1, 26.0, 25.6, 22.5, 14.3, 14.0 ppm; IR (neat) ν~max~ 2935, 1722, 1456, 1163 cm^--1^; HRMS (ESI) *m*/*z* calcd for C~15~H~26~O~4~Na \[M + Na\]^+^ 293.1729, found 293.1728.

To an ice-cold solution of NaBH~4~ (4.56 g, 120.58 mmol) in 30 mL of THF/ethanol solvent mixture (1:1), LiCl (5.10 g, 120.58 mmol) was added. The solution was stirred for 1 h at the same temperature. The above compound (6.52 g, 24.12 mmol) dissolved in anhydrous THF (15 mL) was cannulated, and the reaction mixture was stirred for another 6 h at room temperature. The reaction mixture was cooled to 0 °C and then quenched with a saturated aqueous solution of NH~4~Cl (10 mL). The solvent was removed under reduced pressure. The aqueous part was extracted with EtOAc (3 × 80 mL). The combined organic layers were washed with brine, dried over Na~2~SO~4~, and concentrated in vacuo. Flash column chromatography (SiO~2~, 100--200 mesh, 30% EtOAc in hexane as eluent) of the resultant residue afforded an inseparable mixture of corresponding unsaturated and saturated alcohols (4.85 g). The mixture was dissolved in EtOAc (30 mL) and was hydrogenated for 10 h in the presence of 10% Pd/C (500 mg) using a hydrogen balloon. The reaction mixture was then filtered through celite and concentrated to furnish compound **43** (4.81 g, 86.7%, yield over two steps) as a colorless liquid: *R*~f~ = 0.25 (20% EtOAc/hexane); \[α\]~D~^28^ = −2.0 (*c* 4.2, CHCl~3~); ^1^H NMR (500 MHz, CDCl~3~) δ 4.06--4.04 (m, 2H), 3.70--3.66 (m, 2H), 2.20 (bs, 1H), 1.75--1.55 (m, 2H), 1.53--1.36 (m, 7H), 1.33--1.24 (m, 9H), 0.88 (m, 3H); ^13^C NMR (100 MHz, CDCl~3~) δ 107.6, 78.3, 78.2, 62.9, 32.0, 29.9, 29.8, 28.6, 26.8, 26.0, 22.7, 14.1 ppm; IR (neat) ν~max~ 3407, 2933, 1218, 1029 cm^--1^; HRMS (ESI) *m*/*z* calcd for C~13~H~26~O~3~Na \[M + Na\]^+^ 253.1780, found 253.1782.

### (*E*)-5-((4*S*,5*R*)-2,2-Dimethyl-5-pentyl-1,3-dioxolan-4-yl)pent-2-en-1-ol (**41**) {#sec4.7.16}

Following the procedure similar to that of the synthesis of compound **43**, compound **43** (4.75 g, 20.62 mmol) was converted into the corresponding α,β-unsaturated ester (4.86 g, 79%, purification 100--200 mesh, 5--12% EtOAc in hexane as eluent) as a colored liquid using ethyl(triphenylphosphoranylidene)acetate (14.37 g, 41.24 mmol): *R*~f~ = 0.64 (20% EtOAc/hexane as eluent); \[α\]~D~^27^ = −12.6 (*c* 2.5, CHCl~3~); ^1^H NMR (500 MHz, CDCl~3~) δ 6.97 (m, 1H), 5.83 (d, *J* = 15.5 Hz, 1H), 4.15 (quintet, *J* = 7.0 Hz, 2H), 4.04--3.99 (m, 2H), 2.45--2.40 (m, 1H), 2.25--2.22 (m, 1H), 1.64--1.60 (m, 1H), 1.51--1.45 (m, 3H), 1.44--1.36 (m, 4H), 1.37--1.25 (m, 11H), 0.87 (m, 3H); ^13^C NMR (125 MHz, CDCl~3~) δ 166.7, 148.5, 121.8, 107.6, 78.0, 77.4, 60.3, 32.0, 29.6, 28.9, 28.7, 28.6, 26.1, 26.0, 22.6, 14.3, 14.1 ppm; IR (neat) ν~max~ 2935, 1722, 1654, 1217 cm^--1^; HRMS (ESI) *m*/*z* calcd for C~17~H~30~O~4~Na \[M + Na\]^+^ 321.2042, found 321.2044.

Following the procedure similar to that of the synthesis of compounds **41** and **41a**, the above α,β-unsaturated ester (4.8 g, 16.08 mmol) was converted into pure compound **41** (3.59 g, 87%, purification 100--200 mesh, 25% EtOAc in hexane as eluent) as a colorless liquid using DIBAL-H (1.0 M in toluene, 33.8 mL, 33.77 mmol): *R*~f~ = 0.29 (20% EtOAc/hexane); \[α\]~D~^26^ = −3.2 (*c* 1.9, CHCl~3~); ^1^H NMR (500 MHz, CDCl~3~) δ 5.69--5.60 (m, 2H), 4.05--3.96 (m, 4H), 2.25--2.19 (m, 1H), 2.08--1.95 (m, 2H), 1.59--1.46 (m, 3H), 1.45--1.41 (m, 4H), 1.39--1.21 (m, 9H), 0.85 (t, *J* = 6.5 Hz, 3H); ^13^C NMR (100 MHz, CDCl~3~) δ 132.4, 129.6, 107.5, 78.1, 63.7, 32.0, 29.7, 29.5, 28.9, 28.7, 26.1, 26.0, 22.8, 22.6, 14.1 ppm; IR (neat) ν~max~ 3351, 2936, 1455, 1217 cm^--1^; HRMS (ESI) *m*/*z* calcd for C~15~H~28~O~3~Na \[M + Na\]^+^ 279.1936, found 279.1939.

### (*S*)-4-Benzyl-3-((2*S*,3*R*,*E*)-7-((4*S*,5*R*)-2,2-dimethyl-5-pentyl-1,3-dioxolan-4-yl)-3-hydroxy-2-methylhept-4-enoyl)oxazolidin-2-one (**47**) {#sec4.7.17}

Following the same experimental procedure as that of Swern oxidation as described for the preparation of compounds **41** and **41a**, compound **41** (2.15 g, 8.38 mmol) was converted into the corresponding aldehyde, which was used for the next step without further purification and characterizations.

Following the same experimental procedure as described for the preparation of compounds **40** and **40a**, the above aldehyde was transformed to compound **47** (3.27 g, 80%, purification 230--400 mesh, 18--35% EtOAc in hexane as eluent) as a colorless liquid using oxazolidinone **44** (1.96 g, 8.38 mmol), TiCl~4~ (1.0 mL, 9.22 mmol), DIPEA (1.75 mL, 10.05 mmol), and 1-methyl-2-pyrrolidinone (0.81 mL, 8.38 mmol): *R*~f~ = 0.33 (25% EtOAc/hexane); \[α\]~D~^28^ = +36.8 (*c* 2.7, CHCl~3~); ^1^H NMR (300 MHz, CDCl~3~) δ 7.36--7.27 (m, 3H), 7.22--7.19 (m, 2H), 5.83--5.74 (m, 1H), 5.53 (dd, *J* = 15.3, 6.0 Hz, 1H), 4.74--4.66 (m, 1H), 4.45 (m, 1H), 4.25--4.17 (m, 2H), 4.04--4.00 (m, 2H), 3.86 (m, 1H), 3.25 (dd, *J* = 13.5, 3.3 Hz, 1H), 2.83--2.75 (m, 2H), 2.34--2.22 (m, 1H), 2.16--2.04 (m, 1H), 1.60--1.46 (m, 3H), 1.45--1.42 (m, 3H), 1.42--1.20 (m, 13H), 0.91--0.87 (m, 3H); ^13^C NMR (75 MHz, CDCl~3~) δ 176.8, 153.2, 135.1, 132.7, 129.5, 129.1, 127.5, 107.5, 78.1, 77.4, 72.7, 66.3, 55.3, 42.9, 37.9, 32.0, 29.7, 29.5, 29.0, 28.7, 26.1, 26.1, 22.7, 14.1, 11.3 ppm; IR (neat) ν~max~ 3472, 2934, 2860, 1781, 1698, 1455, 1380, 1217, 771 cm^--1^; HRMS (ESI) *m*/*z* calcd for C~28~H~41~NO~6~Na \[M + Na\]^+^ 510.2832, found 510.2834.

### (2*S*,3*R*,8*S*,9*R*,*E*)-3-((*tert*-Butyldimethylsilyl)oxy)-8,9-dihydroxy-2-methyltetradec-4-enoic Acid (**39**) {#sec4.7.18}

Following the same experimental procedure as described for the preparation of compounds **40** and **40a**, compound **47** (3.15 g, 6.46 mmol) was converted into the corresponding TBS ether (3.52 g, 91%, purification 100--200 mesh, 10% EtOAc in hexane as eluent) as a gummy liquid using 2,6-lutidine (1.76 mL, 16.15 mmol) and TBSOTf (1.8 mL, 7.75 mmol): *R*~f~ = 0.39 (10% EtOAc/hexane); \[α\]~D~^28^ = +35.1 (*c* 3.7, CHCl~3~); ^1^H NMR (300 MHz, CDCl~3~) δ 7.32--7.27 (m, 3H), 7.25--7.19 (m, 2H), 5.66--5.57 (m, 1H), 5.49 (dd, *J* = 15.3, 6.6 Hz, 1H), 4.60--4.55 (m, 1H), 4.27 (t, *J* = 6.3 Hz, 1H), 4.16--4.11 (m, 2H), 4.01--3.95 (m, 3H), 3.26 (dd, *J* = 13.2, 3.0 Hz, 1H), 2.75 (dd, *J* = 13.2, 9.6 Hz, 1H), 2.27--2.15 (m, 1H), 2.10--1.98 (m, 1H), 1.56--1.44 (m, 7H), 1.41--1.29 (m, 9H), 1.30 (d, *J* = 5.4 Hz, 3H), 0.87--0.84 (m, 12H), 0.00 (s, 3H), −0.01 (s, 3H); ^13^C NMR (75 MHz, CDCl~3~) δ 174.9, 153.3, 135.5, 131.7, 131.6, 129.5, 129.0, 127.4, 107.4, 78.0, 77.4, 75.1, 66.0, 55.7, 44.4, 37.9, 32.0, 29.7, 29.5, 28.8, 28.7, 26.1, 26.0, 25.9, 22.7, 18.2, 14.1, 12.7, −4.0, −4.9 ppm; IR (neat) ν~max~ 2932, 2858, 1781, 1698, 1379, 1217, 774 cm^--1^; HRMS (ESI) *m*/*z* calcd for C~34~H~55~NO~6~Na \[M + Na\]^+^ 624.3696, found 624.3697.

Following the same experimental procedure as that described for the preparation of compounds **39** and **39a**, the above compound (3.22 g, 5.35 mmol) was converted into the corresponding acid (1.9 g, 81%, purification 100--200 mesh, 12--18% EtOAc in hexane as eluent) as a clear liquid using LiOH·H~2~O (449 mg, 10.7 mmol) and 30% aqueous H~2~O~2~ (32 mmol): *R*~f~ = 0.41 (20% EtOAc/hexane); \[α\]~D~^24^ = +5.87 (*c* 4.5, CHCl~3~); ^1^H NMR (300 MHz, CDCl~3~) δ 5.72--5.59 (m, 1H), 5.44 (dd, *J* = 15.5, 7.4 Hz, 1H), 4.36--4.30 (m, 1H), 4.05--3.97 (m, 2H), 2.62--2.53 (m, 1H), 2.27--2.16 (m, 1H), 2.13--2.01 (m, 1H), 1.59--1.45 (m, 3H), 1.44--1.40 (m, 3H), 1.39--1.25 (m, 10H), 1.11 (d, *J* = 7.2 Hz, 3H), 0.89--0.87 (m, 12H), 0.07 (s, 3H), 0.04 (s, 3H); ^13^C NMR (75 MHz, CDCl~3~) δ 177.6, 133.1, 129.9, 107.5, 78.1, 77.3, 75.2, 46.1, 32.0, 29.7, 29.4, 28.8, 28.7, 26.1, 26.0, 25.8, 22.7, 18.1, 14.1, 11.7, −4.0, −4.9 ppm; IR (neat) ν~max~ 2954, 2859, 1712, 1250, 1062, 775 cm^--1^; HRMS (ESI) *m*/*z* calcd for C~24~H~46~O~5~SiNa \[M + Na\]^+^ 465.3012, found 465.3011.

Following the same experimental procedure as that described for the preparation of **r39** and **39a**, the above acid (1.1 g, 2.485 mmol) was converted into seco acid **39** (720 mg, 72%, borsm, purification 100--200 mesh, 2--5% MeOH in CH~2~Cl~2~ as eluent) as a liquid using Zn(NO~3~)~2~·6H~2~O (941 mg, 4.97 mmol): *R*~f~ = 0.12 (5% CH~2~Cl~2~/MeOH); \[α\]~D~^27^ = +4.69 (*c* 2.5, CHCl~3~); ^1^H NMR (500 MHz, CDCl~3~) δ 5.64--5.60 (m, 1H), 5.43 (dd, *J* = 15.5, 7.5 Hz, 1H), 4.17 (t, *J* = 7.5 Hz, 1H), 3.58 (m, 2H), 2.53--2.51 (m, 1H), 2.17--2.13 (m, 2H), 1.52--1.48 (m, 2H), 1.48--1.38 (m, 3H), 1.35--1.24 (m, 5H), 1.15 (d, *J* = 7.0 Hz, 3H), 0.89--0.87 (m, 12H), 0.07 (s, 3H), 0.03 (s, 3H); ^13^C NMR (75 MHz, CDCl~3~) δ 177.4, 132.9, 130.7, 75.7, 74.6, 73.8, 47.2, 31.9, 30.6, 30.5, 28.6, 25.8, 25.8, 22.7, 18.2, 14.1, 13.2, −3.9, −4.8 ppm; IR (neat) ν~max~ 3403, 2933, 1713, 1219, 772 cm^--1^; HRMS (ESI) *m*/*z* calcd for C~21~H~42~O~5~SiNa \[M + Na\]^+^ 425.2699, found 425.2697.

### (2*S*,3*R*,8*S*,9*R*,*E*)-8,9-Dihydroxy-3-((4-methoxybenzyl)oxy)-2-methyltetradec-4-enoic Acid (**48**) {#sec4.7.19}

Following the same experimental procedure as that described for the preparation of compounds **39** and **39a**, compound **47** (3.93 g, 8.06 mmol) was converted into the corresponding diol (1.98 g, 78%, purification SiO~2~, 100--200 mesh, 30% EtOAc in hexane as eluent) as a colorless liquid using LiCl (1.71 g, 40.30 mmol) and NaBH~4~ (1.53 g, 40.30 mmol): *R*~f~ = 0.40 (40% EtOAc/hexane); \[α\]~D~^28^ = −2.8 (*c* 1.5, CHCl~3~); ^1^H NMR (300 MHz, CDCl~3~) δ 5.73--5.63 (m, 1H), 5.50 (dd, *J* = 15.3, 6.3 Hz, 1H), 4.21--4.18 (m, 1H), 4.03--3.97 (m, 2H), 3.67--3.54 (m, 2H), 2.95 (bs, 1H), 2.31--2.24 (m, 1H), 2.21--1.93 (m, 1H), 1.93--1.86 (m, 1H), 1.62--1.34 (m, 6H), 1.33--1.27 (m, 10H), 0.91--0.79 (m, 6H); ^13^C NMR (75 MHz, CDCl~3~) δ 132.0, 130.5, 107.5, 78.1, 77.4, 75.9, 66.2, 39.9, 31.9, 29.6, 29.5, 29.0, 28.6, 26.0, 26.0, 22.6, 14.0, 11.6 ppm; IR (neat) ν~max~ 3408, 2930, 2871, 1715, 1456, 1218, 1031 cm^--1^; HRMS (ESI) *m*/*z* calcd for C~18~H~34~O~4~Na \[M + Na\]^+^ 337.2355, found 337.2354.

To a solution of the above diol (1.56 g, 4.97 mmol) in anhydrous CH~2~Cl~2~ (8 mL), *p*-methoxybenzyldimethylacetal (1.69 mL, 9.94 mmol) and CSA (11.6 mg, 0.05 mmol) were added sequentially at 0 °C under argon. The reaction mixture was warmed slowly to room temperature in 1 h and then quenched by Et~3~N (0.5 mL). The solvent was evaporated, and the residue was directly purified by column chromatography (SiO~2~, 100--200, 2--4% EtOAc in hexane as eluent) to yield the corresponding acetals (1.64 g, 77%): *R*~f~ = 0.51 (10% EtOAc/hexane); ^1^H NMR (300 MHz, CDCl~3~) δ 7.43 (d, *J* = 8.7 Hz, 2H), 6.87 (d, *J* = 8.7 Hz, 2H), 5.78--5.70 (m, 1H), 5.56--5.49 (m, 2H), 4.46 (d, *J* = 0.9 Hz, 1H), 4.12--3.98 (m, 4H), 3.77 (s, 3H), 2.25--2.21 (m, 1H), 2.14--2.06 (m, 1H), 1.64--1.56 (m, 2H), 1.55--1.44 (m, 2H), 1.42--1.25 (m, 12H), 1.84 (d, *J* = 6.9 Hz, 3H), 0.89 (m, 3H); ^13^C NMR (75 MHz, CDCl~3~) δ 160.0, 131.5, 131.5, 129.1, 127.6, 113.7, 107.4, 101.8, 80.2, 78.1, 77.5, 73.4, 55.4, 33.2, 32.0, 29.7, 29.4, 29.1, 28.7, 26.1, 26.0, 22.7, 14.1, 11.6 ppm; IR (neat) ν~max~ 2935, 2856, 1616, 1519, 1249, 829 cm^--1^; HRMS (ESI) *m*/*z* calcd for C~26~H~40~O~5~Na \[M + Na\]^+^ 455.2773, found 455.2776.

To a stirred solution of the above acetals (1.60 g, 3.69 mmol) in anhydrous CH~2~Cl~2~ (7 mL) at 0 °C, DIBAL-H (1.0 M solution in toluene, 7.40 mL, 7.40 mmol) was added slowly under argon, and the reaction mixture was stirred for 30 min at the same temperature prior to quenching with MeOH (1 mL). A saturated solution of sodium potassium tartrate (10 mL) was added and stirred further for 1 h until the two layers separated well. The reaction mixture was extracted with EtOAc, washed with water and brine, dried over Na~2~SO~4~, and concentrated in vacuum. Flash column chromatography (SiO~2~, 100--200 mesh, EtOAc/hexane) of the crude residue gave the corresponding primary alcohol (1.35 g, 84%) as a colorless oil: *R*~f~ = 0.32 (20% EtOAc/hexane); \[α\]~D~^24^ = −36.1 (*c* 2.0, CHCl~3~); ^1^H NMR (300 MHz, CDCl~3~) δ 7.22 (d, *J* = 8.7 Hz, 2H), 6.86 (d, *J* = 8.7 Hz, 2H), 5.75--5.65 (m, 1H), 5.50 (dd, *J* = 16.8, 8.1 Hz, 1H), 4.52 (d, *J* = 11.4 Hz, 1H), 4.25 (d, *J* = 11.4 Hz, 1H), 4.08--4.01 (m, 2H), 3.85--3.80 (m, 4H), 3.67--3.63 (m, 1H), 3.61--3.55 (m, 1H), 2.64 (bs, 1H), 2.36--2.24 (m, 1H), 2.21--2.11 (m, 1H), 2.04--1.94 (m, 1H), 1.66--1.58 (m, 2H), 1.54--1.44 (m, 6H), 1.41--1.25 (m, 9H), 0.92--0.85 (m, 6H); ^13^C NMR (75 MHz, CDCl~3~) δ 159.2, 135.0, 130.6, 129.4, 128.0, 113.9, 107.5, 83.1, 78.1, 77.4, 69.8, 66.0, 55.4, 39.8, 32.0, 29.8, 29.6, 29.1, 28.7, 26.1, 26.0, 22.7, 14.1, 12.5 ppm; IR (neat) ν~max~ 3445, 2933, 1612, 1513, 1247, 1036 cm^--1^; HRMS (ESI) *m*/*z* calcd for C~26~H~42~O~5~Na \[M + Na\]^+^ 457.2930, found 457.2931.

Following the same experimental procedure as that described for the preparation of compound **27**, the above alcohol (800 mg, 1.84 mmol) was converted into the corresponding acid (670 mg, 81%, purification SiO~2~, 100--200 mesh, 25--40% EtOAc in hexane as eluent) as a colorless liquid using TEMPO (115 mg, 0.73 mmol) and BAIB (2.37 g, 7.36 mmol): *R*~f~ = 0.43 (30% EtOAc/hexane); \[α\]~D~^26^ = −22.7 (*c* 2.4, CHCl~3~); ^1^H NMR (300 MHz, CDCl~3~) δ 7.22 (d, *J* = 8.7 Hz, 2H), 6.86 (d, *J* = 8.7 Hz, 2H), 5.82--5.72 (m, 1H), 5.42 (dd, *J* = 15.6, 8.4 Hz, 1H), 4.57 (d, *J* = 11.4 Hz, 1H), 4.32 (d, *J* = 11.4 Hz, 1H), 4.04--3.94 (m, 3H), 3.80 (s, 3H), 2.75--2.66 (m, 1H), 2.34--2.25 (m, 1H), 2.21--2.12 (m, 1H), 1.59--1.45 (m, 3H), 1.43--1.40 (m, 4H), 1.39--1.15 (m, 9H), 1.16 (d, *J* = 6.9 Hz, 3H), 0.88 (m, 3H); ^13^C NMR (75 MHz, CDCl~3~) δ 176.9, 159.4, 136.7, 129.8, 129.5, 126.9, 114.0, 107.6, 80.5, 78.1, 77.4, 70.0, 55.4, 44.5, 32.0, 29.7, 29.4, 29.0, 28.7, 26.1, 26.1, 22.7, 14.1, 12.4 ppm; IR (neat) ν~max~ 3421, 2984, 2934, 2859, 1710, 1613, 1514, 1457, 1247, 1059, 1037 cm^--1^; HRMS (ESI) *m*/*z* calcd for C~26~H~40~O~6~Na \[M + Na\]^+^ 471.2722, found 471.2724.

Following the same experimental procedure as that described for the preparation of compounds **39** and **39a**, the above acid (540 mg, 1.2 mmol) was converted into seco acid **48** (413 mg, 84%, purification 100--200 mesh, 4--5% MeOH in CH~2~Cl~2~ as eluent) as a colorless liquid using Zn(NO~3~)~2~·6H~2~O (666 mg, 3.6 mmol): *R*~f~ = 0.23 (5% MeOH/CH~2~Cl~2~); \[α\]~D~^28^ = −26.8 (*c* 4.2, CHCl~3~); ^1^H NMR (300 MHz, CDCl~3~) δ 7.79 (d, *J* = 8.7 Hz, 2H), 6.86 (d, *J* = 8.7 Hz, 2H), 5.76--5.67 (m, 1H), 5.41 (dd, *J* = 15.3, 8.4 Hz, 1H), 4.53 (d, *J* = 11.4 Hz, 1H), 4.28 (d, *J* = 11.4 Hz, 1H), 3.84--3.77 (m, 4H), 3.59 (m, 2H), 2.63 (quintet, *J* = 3.9 Hz, 1H), 2.24--2.17 (m, 2H), 1.57--1.38 (m, 3H), 1.30--1.03 (m, 10H), 0.89 (m, 3H); ^13^C NMR (75 MHz, CDCl~3~) δ 177.5, 159.3, 136.1, 130.2, 129.5, 128.3, 113.9, 81.1, 74.5, 73.8, 70.0, 55.4, 45.6, 31.9, 30.6, 29.8, 28.7, 25.8, 22.7, 14.1, 13.6 ppm; IR (neat) ν~max~ 3413, 2929, 2858, 1710, 1610, 1514, 1465, 821 cm^--1^; HRMS (ESI) *m*/*z* calcd for C~23~H~36~O~6~Na \[M + Na\]^+^ 431.2410, found 431.2412.

### (6*S*,7*R*,*E*)-7-((*tert*-Butyldimethylsilyl)oxy)-6-(methoxymethoxy)dodec-2-en-1-ol (**49**) {#sec4.7.20}

Following the same experimental procedure as that described for the preparation of compound **8**, compound **22** (6.7 g, 22.29 mmol) was converted into the corresponding MOM ether (6.52 g, 85%, purification 100--200 mesh, 3--6% EtOAc in hexane as eluent) as a pale yellow oil using DIPEA (7.76 mL, 44.58 mmol) and MOMCl (2.56 mL, 33.44 mmol): *R*~f~ = 0.52 (5% EtOAc/hexane); \[α\]~D~^25^ = −46.2 (*c* 5.2, CHCl~3~); ^1^H NMR (300 MHz, CDCl~3~) δ 5.84--5.75 (m, 1H), 5.07--4.98 (m, 2H), 4.78 (d, *J* = 6.6 Hz, 1H), 4.61 (d, *J* = 6.6 Hz, 1H), 3.69--3.64 (m, 1H), 3.54--3.50 (m, 1H), 3.49 (s, 3H), 2.31--2.19 (m, 1H), 2.12--2.06 (m, 1H), 1.65--1.23 (m, 10H), 0.94--0.86 (m, 12H), 0.06 (s, 3H), 0.05 (s, 3H); ^13^C NMR (75 MHz, CDCl~3~) δ 138.8, 114.7, 96.2, 80.0, 74.7, 55.9, 33.0, 32.2, 30.3, 30.0, 26.0, 25.7, 22.7, 18.3, 14.2, −4.0, −4.5 ppm; IR (neat) ν~max~ 3078, 2930, 1641, 1471, 1253, 1038 cm^--1^; HRMS (ESI) *m*/*z* calcd for C~19~H~40~O~3~SiNa \[M + Na\]^+^ 367.2638, found 367.2647.

To an ice-cold solution of the above compound (3.52 g, 10.21 mmol) in a mixture of THF (20 mL) and water (20 mL), NaIO~4~ (8.73 g, 40.84 mmol) and OsO~4~ (5% solution in ^*t*^BuOH, 4 mL) were added sequentially. The reaction mixture was warmed to room temperature and stirred for another 6 h. The reaction mixture was then passed through a sintered funnel and washed with EtOAc. The organic layer was separated. The aqueous part was extracted with EtOAc (2 × 30 mL). The combined organic extracts were washed with brine, dried (Na~2~SO~4~), and concentrated in vacuo to get the crude aldehyde, which was taken directly to the next reaction without further purification and characterization.

The above aldehyde was dissolved in anhydrous toluene (50 mL), and ethyl(triphenylphosphoranylidene)acetate (7.1 g, 20.42 mmol) was added. The solution was heated to 80 °C for 6 h. The reaction mixture was cooled to room temperature, and the solvent was evaporated. The residue was purified using flash column chromatography (SiO~2~, 100--200 mesh, 5% EtOAc in hexane as eluent) to obtain the corresponding α,β-unsaturated ester (3.44 g, 81%) as a yellowish liquid: *R*~f~ = 0.45 (5% EtOAc/hexane); \[α\]~D~^28^ = −23.5 (*c* 4.6, CHCl~3~); ^1^H NMR (300 MHz, CDCl~3~) δ 6.98 (dt, *J* = 15.6, 6.9 Hz, 1H), 5.83 (dt, *J* = 15.6, 1.8 Hz, 1H), 4.75 (d, *J* = 6.6 Hz, 1H), 4.59 (d, *J* = 6.6 Hz, 1H), 4.17 (q, *J* = 7.2 Hz, 2H), 3.68--3.64 (m, 1H), 3.48 (ddd*, J* = 6.3, 3.0, 3.0 Hz, 1H), 3.37 (s, 3H), 2.39--2.36 (m, 1H), 2.26--2.21 (m, 1H), 1.72--1.59 (m, 2H), 1.58--1.37 (m, 2H), 1.35--1.20 (m, 9H), 0.90--0.85 (m, 12H), 0.05 (s, 3H), 0.04 (s, 3H); ^13^C NMR (75 MHz, CDCl~3~) δ 166.8, 149.1, 121.6, 96.1, 79.9, 74.4, 60.3, 56.0, 33.3, 32.1, 28.8, 28.7, 26.0, 25.6, 22.7, 18.3, 14.4, 14.1, −4.1, −4.5 ppm; IR (neat) ν~max~ 2931, 1722, 1654, 1465, 1255, 1035 cm^--1^; HRMS (ESI) *m*/*z* calcd for C~22~H~44~O~5~SiNa \[M + Na\]^+^ 439.2856, found 439.2857.

Following the same experimental procedure as described for the preparation of compound **41**, the above ester (3.31 g, 7.94 mmol) was converted into alcohol **49** (2.53 g, 85%, purification 100--200 mesh, 16% EtOAc in hexane as eluent) as a colorless liquid using DIBAL-H (1.0 M in toluene, 16.3 mL, 16.28 mmol): *R*~f~ = 0.36 (20% EtOAc/hexane); \[α\]~D~^25^ = −18.4 (*c* 1.1, CHCl~3~); ^1^H NMR (300 MHz, CDCl~3~) δ 5.74--5.60 (m, 2H), 4.76 (d, *J* = 6.9 Hz, 1H), 4.60 (d, *J* = 6.9 Hz, 1H), 4.06 (m, 2H), 3.67--3.62 (m, 1H), 3.51--3.46 (m, 1H), 3.38 (s, 3H), 2.27--2.15 (m, 1H), 2.12--2.03 (m, 1H), 1.67--1.22 (m, 10H), 0.89--0.85 (m, 12H), 0.04 (s, 3H), 0.02 (s, 3H); ^13^C NMR (75 MHz, CDCl~3~) δ 133.0, 129.5, 96.2, 80.0, 74.6, 63.8, 55.8, 33.0, 32.1, 30.0, 28.8, 26.0, 25.9, 25.6, 22.7, 18.2, 14.1, −4.0, −4.5 ppm; IR (neat) ν~max~ 3400, 2954, 2930, 2857, 1471, 1253, 1096, 1036, 835, 774 cm^--1^; HRMS (ESI) *m*/*z* calcd for C~20~H~42~O~4~SiNa \[M + Na\]^+^ 397.2750, found 397.2752.

### (*S*)-4-Benzyl-3-((2*S*,3*R*,8*S*,9*R*,*E*)-9-((*tert*-butyldimethylsilyl)oxy)-3-hydroxy-8-(methoxymethoxy)-2-methyltetradec-4-enoyl)oxazolidin-2-one (**50**) {#sec4.7.21}

Following the same experimental procedure as that of Swern oxidation as described for the preparation of compounds **41** and **41a**, alcohol **49** (2.41 g, 6.43 mmol) was converted into the corresponding aldehyde, which was used for the next step without further purification and characterizations.

Following the same experimental procedure as described for the preparation of compounds **40** and **40a**, the above aldehyde was transformed to compound **50** (3.0 mg, 77%, purification 230--400 mesh, 14--28% EtOAc in hexane as eluent) as a colorless liquid using oxazolidinone **44** (1.5 g, 6.43 mmol), TiCl~4~ (0.78 mL, 7.07 mmol), DIPEA (1.34 mL, 7.72 mmol), and 1-methyl-2-pyrrolidinone (0.62 mL, 6.43 mmol): *R*~f~ = 0.33 (20% EtOAc/hexane); \[α\]~D~^29^ = +13.58 (*c* 3.1, CHCl~3~); ^1^H NMR (300 MHz, CDCl~3~) δ 7.36--7.19 (m, 5H), 5.79--5.74 (m, 1H), 5.55 (dd, *J* = 15.6, 6.3 Hz, 1H), 4.77 (d, *J* = 6.6 Hz, 1H), 4.72--4.67 (m, 1H), 4.60 (d, *J* = 6.6 Hz, 1H), 4.44 (t, *J* = 7.2 Hz, 1H), 4.25--4.16 (m, 2H), 3.90--3.85 (m, 1H), 3.67--3.65 (m, 1H), 3.52--3.49 (m, 1H), 3.39 (s, 3H), 3.25 (dd, *J* = 13.5, 3.3 Hz, 1H), 2.79 (dd, *J* = 13.5, 9.9 Hz, 1H), 2.32--2.21 (m, 1H), 2.18--2.03 (m, 1H), 1.56--1.42 (m, 4H), 1.40--1.19 (m, 9H), 0.85--0.79 (m, 12H), 0.06--0.04 (m, 6H); ^13^C NMR (75 MHz, CDCl~3~) δ 176.7, 153.2, 135.1, 133.1, 129.5, 129.4, 129.0, 127.5, 96.0, 80.1, 74.6, 72.7, 66.3, 55.9, 55.3, 42.9, 37.9, 33.1, 32.1, 30.1, 28.9, 26.0, 25.6, 22.7, 18.3, 14.1, 11.3, −4.0, −4.5 ppm; IR (neat) ν~max~ 3521, 2856, 1784, 1697, 1456, 1386, 1213 cm^--1^; HRMS (ESI) *m*/*z* calcd for C~33~H~55~NO~7~SiNa \[M + Na\]^+^ 628.3646, found 628.3647.

### (2*S*,3*R*,8*S*,9*R*,*E*)-3,9-Dihydroxy-8-(methoxymethoxy)-2-methyltetradec-4-enoic Acid (**51**) {#sec4.7.22}

To an ice-cold solution of compound **50** (530 mg, 0.87 mmol) in anhydrous THF (5 mL), HF-pyridine (0.5 mL) was added. The reaction mixture was warmed slowly to room temperature and stirred for 3 h. The reaction mixture was cooled to 0 °C and quenched with a saturated solution of NaHCO~3~ (5 mL). The mixture was extracted with CH~2~Cl~2~ (3 × 15 mL), washed with water and brine, dried over Na~2~SO~4~, and concentrated in vacuo. Purification of the crude residue by flash column chromatography (SiO~2~, 100--200 mesh, EtOAc in hexane as eluent) gave the corresponding desilylated compound (375 mg, 88%) as a colorless liquid: *R*~f~ = 0.18 (35% EtOAc/hexane); \[α\]~D~^30^ = +15.6 (*c* 0.53, CHCl~3~); ^1^H NMR (300 MHz, CDCl~3~) δ 7.35--7.18 (m, 5H), 5.81--5.69 (m, 1H), 5.52 (dd, *J* = 15.3, 6.0 Hz, 1H), 4.74--4.67 (m, 2H), 4.63 (d, *J* = 6.9 Hz, 1H), 4.43 (t, *J* = 5.1 Hz, 1H), 4.25--4.16 (m, 2H), 3.88--3.84 (m, 1H), 3.58 (m, 1H), 3.50 (dt, *J* = 9.0, 3.3 Hz, 1H), 3.41 (s, 3H), 3.25 (dd, *J* = 13.5, 3.3 Hz, 1H), 2.78 (dd, *J* = 13.5, 9.9 Hz, 2H), 2.31--2.20 (m, 1H), 2.19--2.03 (m, 1H), 1.69--1.62 (m, 2H), 1.55--1.42 (m, 2H), 1.48--1.23 (m, 9H), 0.91--0.86 (m, 3H); ^13^C NMR (75 MHz, CDCl~3~) δ 176.7, 153.3, 135.1, 132.7, 129.7, 129.5, 129.1, 127.5, 97.3, 83.4, 73.1, 72.7, 66.3, 55.9, 55.3, 42.9, 37.9, 32.0, 31.7, 29.7, 28.7, 26.0, 22.7, 14.1, 11.4 ppm; IR (neat) ν~max~ 3545, 2875, 1765, 1680, 1464, 1387, 1212 cm^--1^; HRMS (ESI) *m*/*z* calcd for C~27~H~41~NO~7~SNa \[M + Na\]^+^ 514.2781, found 514.2780.

To a stirred THF/water (3:1) (8 mL) solution of the above compound (80 mg, 1.64 mmol) at 0 °C, 30% aqueous H~2~O~2~ (9.84 mmol) and LiOH·H~2~O (138 mg, 3.28 mmol) were added sequentially. The reaction mixture was warmed slowly to room temperature and stirred further for 6 h prior to neutralization with 1 N HCl. The mixture was extracted with EtOAc (3 × 15 mL), washed with water and brine, dried over Na~2~SO~4~, and concentrated in vacuo. The organic layer was concentrated in reduced pressure, and the residue was purified by column chromatography (SiO~2~, 100--200 mesh, 2--5% MeOH in CH~2~Cl~2~ as eluent) to give acid **51** (454 mg, 84%) as a clear liquid: *R*~f~ = 0.58 (10% MeOH/CH~2~Cl~2~); ^1^H NMR (300 MHz, CDCl~3~) δ 5.78--5.68 (m, 1H), 5.59--5.46 (m, 1H), 4.72--4.62 (m, 3H), 3.55--3.50 (m, 2H), 3.41 (s, 3H), 2.65 (s, 1H), 2.21--2.01 (m, 2H), 1.64--1.61 (m, 1H), 1.51--1.47 (m, 1H), 1.44--1.24 (m, 8H), 1.22--1.15 (m, 3H), 0.90--0.85 (m, 3H); ^13^C NMR (75 MHz, CDCl~3~) δ 178.5, 133.0, 129.9, 97.3, 83.2, 73.2, 55.9, 32.0, 31.5, 31.3, 29.9, 29.8, 29.7, 28.5, 25.9, 22.7, 14.1 ppm; HRMS (ESI) *m*/*z* calcd for C~17~H~32~NO~6~Na \[M + Na\]^+^ 355.2097, found 355.2096.

The Supporting Information is available free of charge on the [ACS Publications website](http://pubs.acs.org) at DOI: [10.1021/acsomega.7b01893](http://pubs.acs.org/doi/abs/10.1021/acsomega.7b01893).Copies of NMR (^1^H and ^13^C) and HRMS of representative compounds; 2D-NMR data of compounds **15**, **23**, **29**, **38**, and **45** ([PDF](http://pubs.acs.org/doi/suppl/10.1021/acsomega.7b01893/suppl_file/ao7b01893_si_001.pdf))
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